{"code":"!function(t){var e={};function n(i){if(e[i])return e[i].exports;var a=e[i]={i:i,l:!1,exports:{}};return t[i].call(a.exports,a,a.exports,n),a.l=!0,a.exports}n.m=t,n.c=e,n.d=function(t,e,i){n.o(t,e)||Object.defineProperty(t,e,{enumerable:!0,get:i})},n.r=function(t){\"undefined\"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(t,Symbol.toStringTag,{value:\"Module\"}),Object.defineProperty(t,\"__esModule\",{value:!0})},n.t=function(t,e){if(1&e&&(t=n(t)),8&e)return t;if(4&e&&\"object\"==typeof t&&t&&t.__esModule)return t;var i=Object.create(null);if(n.r(i),Object.defineProperty(i,\"default\",{enumerable:!0,value:t}),2&e&&\"string\"!=typeof t)for(var a in t)n.d(i,a,function(e){return t[e]}.bind(null,a));return i},n.n=function(t){var e=t&&t.__esModule?function(){return t.default}:function(){return t};return n.d(e,\"a\",e),e},n.o=function(t,e){return Object.prototype.hasOwnProperty.call(t,e)},n.p=\"\",n(n.s=9)}([function(t,e,n){\"use strict\";var i=n(8);t.exports={getTranslatedText:function(t,e){var n=i[t][e];return n||e},strReplace:function(t,e,n){return t.replace(e,n)}}},function(t,e,n){\"use strict\";var i=n(0).getTranslatedText,a=[{title:\"text0009\",languages:{en:\"./assets/docs/aenco-whitepaper.pdf\",zhcn:\"./assets/docs/aenco-whitepaper-cn.pdf\",kr:\"./assets/docs/aenco-whitepaper-kr.pdf\"}},{title:\"text0010\",languages:{en:\"./assets/docs/aenco-token-economics.pdf\",zhcn:\"./assets/docs/aenco-token-economics-cn.pdf\",kr:\"./assets/docs/aenco-token-economics-kr.pdf\"}},{title:\"text0011\",languages:{en:\"./assets/docs/aenco-two-pager.pdf\",zhcn:\"./assets/docs/aenco-two-pager-cn.pdf\"}},{title:\"text0012\",languages:{en:\"./assets/docs/aenco-presentation.pdf\",zhcn:\"./assets/docs/aenco-presentation-cn.pdf\"}},{title:\"TERMS OF USE\",languages:{en:\"./assets/docs/aenco-terms-conditions.pdf\"}},{title:\"text0185\",languages:{en:\"./assets/docs/disclaimer.pdf\"}},{title:\"text0186\",languages:{en:\"./assets/docs/privacy-policy.pdf\"}}];t.exports={getPdfDoc:function(t,e){var n=a[t],o=n.languages[e]?n.languages[e]:n.languages.en;return{title:i(e,n.title),path:o}}}},function(t,e,n){\"use strict\";t.exports={teamMemberData:[{name:\"text3001\",title:\"text3002\",image:\"./assets/img/profile/ian-huen.png\",linkedin:\"https://www.linkedin.com/in/ianhuen/\",id:1},{name:\"text3012\",title:\"text3013\",image:\"./assets/img/profile/darren-lui.png\",linkedin:\"https://www.linkedin.com/in/darren-lui/\",id:2},{name:\"text3022\",title:\"text3023\",image:\"./assets/img/profile/kenrick-fok.png\",linkedin:\"https://www.linkedin.com/in/kenrickfok/\",id:3},{name:\"text3031\",title:\"text3032\",image:\"./assets/img/profile/geoffrey-tipton.png\",linkedin:\"https://www.linkedin.com/in/geoff-tipy/\",id:4},{name:\"text3040\",title:\"text3041\",image:\"./assets/img/profile/charles-lau.png\",linkedin:\"https://www.linkedin.com/in/laucharles\",id:5},{name:\"text3047\",title:\"text3048\",image:\"./assets/img/profile/erica-chan.png\",linkedin:\"https://www.linkedin.com/in/erica-chan/\",id:6},{name:\"text3054\",title:\"text3055\",image:\"./assets/img/profile/nick-wan.png\",linkedin:\"https://www.linkedin.com/in/nickhywan/\",id:7},{name:\"text3063\",title:\"text3064\",image:\"./assets/img/profile/calvin-poon.png\",linkedin:\"https://www.linkedin.com/in/calvin-poon/\",id:8},{name:\"text3071\",title:\"text3072\",image:\"./assets/img/profile/ally-cheung.png\",linkedin:\"https://www.linkedin.com/in/allycheung/\",id:9},{name:\"text3079\",title:\"text3080\",image:\"./assets/img/profile/david-carey.png\",linkedin:\"https://www.linkedin.com/in/david-carey/\",id:10},{name:\"text3088\",title:\"text3089\",image:\"./assets/img/profile/michelle-au.png\",linkedin:\"https://www.linkedin.com/in/michelleaudesign/\",id:11},{name:\"text3097\",title:\"text3098\",image:\"./assets/img/profile/issac-cheung.png\",linkedin:\"https://www.linkedin.com/in/issac-cheung-6b02a1147/\",id:12},{name:\"text3103\",title:\"text3104\",image:\"./assets/img/profile/isabella-lai.png\",linkedin:\"https://www.linkedin.com/in/isabella-lai/\",id:13},{name:\"text3110\",title:\"text3111\",image:\"./assets/img/profile/teddy-ip.png\",linkedin:\"https://www.linkedin.com/in/teddyip/\",id:14},{name:\"text3118\",title:\"text3119\",image:\"./assets/img/profile/andy-chan.png\",linkedin:\"https://www.linkedin.com/in/atmchan/\",id:15},{name:\"text3126\",title:\"text3127\",image:\"./assets/img/profile/aaron-regala.png\",linkedin:\"https://www.linkedin.com/in/aaron-regala/\",id:16}],advisorsData:[{name:\"text3132\",title:\"text3133\",image:\"./assets/img/profile/doug-arner.png\",linkedin:\"http://www.law.hku.hk/faculty/staff/arner_douglas.php\",id:1,desc:[\"text3134\",\"text3135\",\"text3136\",\"text3137\",\"text3138\",\"text3139\",\"text3140\"]},{name:\"text3141\",title:\"text3142\",image:\"./assets/img/profile/sm-yiu.png\",linkedin:\"https://www.cs.hku.hk/people/profile.jsp?teacher=smyiu\",id:2,desc:[\"text3143\",\"text3144\",\"text3145\",\"text3146\",\"text3147\",\"text3148\",\"text3149\"]},{name:\"text3150\",title:\"text3151\",image:\"./assets/img/profile/jeff-marquass.png\",linkedin:\"https://www.linkedin.com/in/jeff-marquass-4a37995/\",id:3,desc:[\"text3152\",\"text3153\",\"text3154\",\"text3155\"]},{name:\"text3156\",title:\"text3157\",image:\"./assets/img/profile/julian-ting.png\",linkedin:\"https://www.linkedin.com/in/julianywting/\",id:4,desc:[\"text3158\",\"text3159\",\"text3160\",\"text3161\",\"text3162\"]},{name:\"text3163\",title:\"text3164\",image:\"./assets/img/profile/kenny-yu.png\",linkedin:\"https://www.researchgate.net/profile/Kenny_Yu\",id:5,desc:[\"text3165\",\"text3166\",\"text3167\",\"text3168\"]},{name:\"text3169\",title:\"text3170\",image:\"./assets/img/profile/william-wu.png\",linkedin:\"https://www.lihs.cuhk.edu.hk/en-us/research/investigators/wu,kakeiwilliam.aspx\",id:6,desc:[\"text3171\",\"text3172\",\"text3173\",\"text3174\",\"text3175\"]},{name:\"text3176\",title:\"text3177\",image:\"./assets/img/profile/sunny-wong.png\",linkedin:\"http://www.mect.cuhk.edu.hk/people/sunnywong.html\",id:7,desc:[\"text3178\",\"text3179\",\"text3180\",\"text3181\",\"text3182\"]},{name:\"text3183\",title:\"text3184\",image:\"./assets/img/profile/albert-leung.png\",linkedin:\"https://www.bloomberg.com/research/stocks/people/person.asp?personId=53151654&amp;capId=883253&amp;previousCapId=141391086&amp;previousTitle=GOLDENWAY%20INC\",id:8,desc:[\"text3185\",\"text3186\",\"text3187\",\"text3188\",\"text3189\",\"text3190\",\"text3191\",\"text3192\"]},{name:\"text3193\",title:\"text3194\",image:\"./assets/img/profile/kwok-ka-wai.png\",linkedin:\"http://hub.hku.hk/cris/rp/rp01924\",id:9,desc:[\"text3195\",\"text3196\",\"text3197\",\"text3198\",\"text3199\"]},{name:\"text3200\",title:\"text3201\",image:\"./assets/img/profile/joe-hui.png\",linkedin:\"https://icb.hkuspace.hku.hk/chs/staff/detail/joe-hui\",id:10,desc:[\"text3202\",\"text3203\",\"text3204\",\"text3205\",\"text3206\",\"text3207\",\"text3208\"]},{name:\"text3209\",title:\"text3210\",image:\"./assets/img/profile/owen-ko.png\",linkedin:\"http://www.mect.cuhk.edu.hk/people/owenko.html\",id:11,desc:[\"text3211\",\"text3212\",\"text3213\",\"text3214\"]},{name:\"text3215\",title:\"text3216\",image:\"./assets/img/profile/shell-chung.png\",linkedin:\"https://www.alpacian.com/\",id:12,desc:[\"text3217\",\"text3218\",\"text3219\",\"text3220\",\"text3221\"]},{name:\"text3222\",title:\"text3223\",image:\"./assets/img/profile/kevin-chan.png\",linkedin:\"http://www.cachetam.com/en/management.php\",id:13,desc:[\"text3224\",\"text3225\",\"text3226\",\"text3227\",\"text3228\",\"text3229\"]},{name:\"text3236\",title:\"text3237\",image:\"./assets/img/profile/virginia-lam.png\",linkedin:\"https://www.linkedin.com/in/lamvirginia/\",id:15,desc:[\"text3238\",\"text3239\",\"text3240\",\"text3241\",\"text3242\",\"text3243\",\"text3244\"]},{name:\"text3245\",title:\"text3246\",image:\"./assets/img/profile/douglas-ching.png\",linkedin:\"https://www.linkedin.com/in/dougching/\",id:16,desc:[\"text3247\",\"text3248\",\"text3249\",\"text3250\",\"text3251\",\"text3252\"]}]}},function(t,e,n){\"use strict\";var i=n(0).getTranslatedText,a=n(0).strReplace,o=n(1).getPdfDoc,s={getContributionSection:function(t){var e=this.getContributionsContent(t);return'<section class=\"section learn-more-area\" id=\"contribution-area\">\\n                    '.concat(e,\"\\n                </section>\")},getLearnMoreContent:function(t){var e=this.getContributionsContent(t),n=o(0,t).path,s=o(1,t).path,r=o(4,t).path,x=i(t,\"text2002\");x=a(x,\"<a>\",'<a target=\"_blank\" href=\"'+s+'\">'),x=a(x,\"<a>\",'<a target=\"_blank\" href=\"'+r+'\">');var l=i(t,\"text2003\"),c=i(t,\"text2004\"),d=i(t,\"text2006\"),u=i(t,\"text2007\"),g=i(t,\"text2008\"),m=i(t,\"text2009\"),h=i(t,\"text2010\"),p=i(t,\"text2011\"),f=i(t,\"text2012\"),v=i(t,\"text2013\"),A=i(t,\"text2014\"),C=i(t,\"text2015\");C=a(C,\"<a>\",'<a target=\"_blank\" href=\"'+n+'\">'),C=a(C,\"<a>\",'<a target=\"_blank\" href=\"'+s+'\">');var b=i(t,\"text2016\"),w=i(t,\"text2017\"),E=i(t,\"text2018\"),y=i(t,\"text2019\"),S=i(t,\"text2020\"),k=i(t,\"text2021\"),T=i(t,\"text2022\");r=o(4,t).path;T=a(T,\"<a>\",'<a target=\"_blank\" href=\"'+r+'\">');var N=i(t,\"text2023\");N=a(N,\"<a>\",'<a target=\"_blank\" href=\"https://signup.aencoin.com/register\">');var I=i(t,\"text2024\"),O=i(t,\"text2039\");return'<section class=\"section learn-more-area\" id=\"token-sale-terms\">\\n                    <div class=\"container\">\\n                        \\x3c!-- Token Sale Terms Summary --\\x3e\\n                        <p>'.concat(x,\"</p>\\n                        <p>\").concat(l,'</p>\\n                        <div class=\"sub-section section-private-sale\">\\n                            <h4>').concat(c,\"</h4>\\n                            <table>\\n                                <tr>\\n                                    <td>\").concat(d,\"</td>\\n                                    <td>\").concat(u,\"</td>\\n                                </tr>\\n                                <tr>\\n                                    <td>\").concat(g,\"</td>\\n                                    <td>\").concat(m,\"</td>\\n                                </tr>\\n                                <tr>\\n                                    <td>\").concat(h,\"</td>\\n                                    <td>\").concat(p,\"</td>\\n                                </tr>\\n                                <tr>\\n                                    <td>\").concat(f,\"</td>\\n                                    <td>\").concat(v,'</td>\\n                                </tr>\\n                            </table>\\n                        </div>\\n                        <div class=\"sub-section section-pre-sale\">\\n                            <h4>').concat(A,\"</h4>\\n                            <p>\").concat(C,'</p>\\n                            <table>\\n                                <tr>\\n                                    <td class=\"w30\">').concat(b,\"</td>\\n                                    <td>\").concat(w,'</td>\\n                                </tr>\\n                                <tr>\\n                                    <td class=\"w30\">').concat(E,\"</td>\\n                                    <td>\").concat(y,'</td>\\n                                </tr>\\n                                <tr>\\n                                    <td class=\"w30\">').concat(S,\"</td>\\n                                    <td>\").concat(O,'</td>\\n                                </tr>\\n                            </table>\\n                        </div>\\n                        <div class=\"sub-section section-eligibility\">\\n                            <h4>').concat(k,\"</h4>\\n                            <ul>\\n                                <li>\").concat(T,\"</li>\\n                                <li>\").concat(N,\"</li>\\n                                <li>\").concat(I,\"</li>\\n                            </ul>\\n                        </div>\\n                        \").concat(e,\"\\n                    </div>\\n                </section>\")},getContributionsContent:function(t){var e=i(t,\"text2025\"),n=i(t,\"text2026\"),o=i(t,\"text2027\"),s=i(t,\"text2028\"),r=i(t,\"text2029\");r=a(r,\"<a>\",'<a target=\"_blank\" href=\"https://sanctionssearch.ofac.treas.gov/\">');var x=i(t,\"text2030\"),l=i(t,\"text2031\"),c=i(t,\"text2032\"),d=i(t,\"text2033\"),u=i(t,\"text2034\"),g=i(t,\"text2035\"),m=i(t,\"text2036\");return'<div class=\"sub-section\">\\n                    <div class=\"sub-header\">'.concat(e,\"</div>\\n                    <ul>\\n                        <li>\").concat(n,\"</li>\\n                        <li>\").concat(o,\"</li>\\n                        <li>\").concat(s,\"</li>\\n                        <li>\").concat(r,'</li>\\n                    </ul>\\n                </div>\\n                <div class=\"sub-section\">\\n                    <div class=\"sub-header\">').concat(x,\"</div>\\n                    <ul>\\n                        <li>\").concat(l,\"</li>\\n                        <li>\").concat(c,\"</li>\\n                        <li>\").concat(d,'</li>\\n                    </ul>\\n                </div>\\n                <div class=\"sub-section\">\\n                    <div class=\"sub-header\">').concat(u,\"</div>\\n                    <ul>\\n                        <li>\").concat(g,\"</li>\\n                        <li>\").concat(m,\"</li>\\n                    </ul>\\n                </div>\")}};t.exports=s},function(t,e,n){\"use strict\";var i=n(0).getTranslatedText,a=[{label:\"text0111\",value:50},{label:\"text0113\",value:21},{label:\"text0115\",value:15},{label:\"text0117\",value:14}],o=[{label:\"text0122\",value:40},{label:\"text0124\",value:30},{label:\"text0126\",value:24},{label:\"text0128\",value:3},{label:\"text0130\",value:3}],s=[\"#b1d349\",\"#95cb74\",\"#87c786\",\"#66c0a5\",\"#076f7d\",\"#0d8596\",\"#15b8ce\"];function r(t){return t*Math.PI/180}function x(t,e,n,i,a){var o=Math.sqrt(e*e+n*n),s=180*Math.atan2(n,e)/Math.PI;return s<0&&(s=360+s),s>=i&&s<=a&&o<=t}function l(t,e,n,i,a,o,s,r,x,l,c){t.fillStyle=s,t.beginPath(),t.moveTo(e,n),t.arc(e,n,i,a,o),t.closePath(),t.fill(),r&&(t.font=\"24px Teko\",t.fillStyle=\"#FFFFFF\",t.fillText(c,x,l))}t.exports={charts:[],updateTable:function(t){for(var e=\"\",n=\"\",s=0;s<a.length;s++)n=i(t,a[s].label),e+='<div class=\"row item'.concat(s,'\">\\n                        <div class=\"col col-2\"><h5>').concat(a[s].value,'%</h5></div>\\n                        <div class=\"col\"><h5>').concat(n,\"</h5></div>\\n                    </div>\");$(\"#token-allocation\").html(e),e=\"\";for(var r=0;r<o.length;r++)n=i(t,o[r].label),e+='<div class=\"row item'.concat(r,'\">\\n                        <div class=\"col col-2\"><h5>').concat(o[r].value,'%</h5></div>\\n                        <div class=\"col\"><h5>').concat(n,\"</h5></div>\\n                    </div>\");$(\"#use-of-proceeds\").html(e)},getPieChart:function(){return{state:{selectedSegment:-1},props:{},setState:function(t){t.selectedSegment!==this.state.selectedSegment&&(this.state.selectedSegment=t.selectedSegment,this.render(this.props))},getState:function(){return this.state},getSegment:function(t,e,n){t.offset;for(var i=t.width,a=(t.height,0),o=0,s=t.data,r=[],l=[],c=0;c<s.length;c++){var d=s[c]/100*360;r.push(a),o=a+d,l.push(o),a=o}for(var u=i/2,g=e-i/2,m=n-i/2,h=0;h<r.length;h++)if(x(u,g,m,r[h],l[h]))return h;return-1},render:function(t){var e=this;e.props=t;var n=e.state,i=document.getElementById(t.selector),a=t.onMouseMoveCallback,o=t.onMouseOutCallback,x=t.data,c=t.offset,d=t.width,u=t.height;i.addEventListener(\"mousemove\",function(n){var i=n.offsetX,o=n.offsetY,s=e.getSegment(t,i,o);e.setState({selectedSegment:s}),a&&a(s)}),i.addEventListener(\"mouseout\",function(){e.setState({selectedSegment:-1}),o&&o()}),i.width=d,i.height=u;for(var g=i.getContext(\"2d\"),m=0,h=0,p=0,f=(d-4*c)/2,v=d/2,A=d/2,C=0,b=0,w=\"\",E=!1,y=0,S=0;S<x.length;S++)h=m+x[S]/100*360,S===n.selectedSegment?(p=f+c,y=r((m+h)/2),v+=Math.cos(y)*c,A+=Math.sin(y)*c,C=v+Math.cos(y)*(f-30),b=A+Math.sin(y)*(f-30),C-=15,b+=8,w=x[S]+\"%\",E=!0):(p=f,v=d/2,A=d/2,E=!1),l(g,v,A,p,r(m),r(h),s[S],E,C,b,w),m=h}}},render:function(){for(var t=$(\"#token-allocation\"),e=$(\"#use-of-proceeds\"),n=[],i=[],r=Math.ceil(4),x=0;x<a.length;x++)n.push(a[x].value);for(var l=0;l<o.length;l++)i.push(o[l].value);var c={selector:\"allocation-pie\",data:n,offset:r,width:200,height:200,onMouseMoveCallback:function(e){t.find(\".row\").css(\"background-color\",\"transparent\"),t.find(\".row.item\"+e).css(\"background-color\",s[e])},onMouseOutCallback:function(){t.find(\".row\").css(\"background-color\",\"transparent\")}},d={selector:\"use-of-proceeds-pie\",data:i,offset:r,width:200,height:200,onMouseMoveCallback:function(t){e.find(\".row\").css(\"background-color\",\"transparent\"),e.find(\".row.item\"+t).css(\"background-color\",s[t])},onMouseOutCallback:function(){e.find(\".row\").css(\"background-color\",\"transparent\")}};0===this.charts.length&&(this.charts.push(this.getPieChart()),this.charts.push(this.getPieChart())),this.charts[0].render(c),this.charts[1].render(d)}}},function(t,e,n){\"use strict\";t.exports=[{id:1,path:\"./assets/img/video-aenco-explained.jpg\",label:\"text0046\",url:{en:\"https://www.youtube.com/embed/r9zOftJvvPE\"}},{id:2,path:\"./assets/img/video-rollout-thumb.jpg\",label:\"text0047\",url:{en:\"https://www.youtube.com/embed/Vv4lgRwoX08?rel=0\",zhcn:\"https://www.youtube.com/embed/N6cqIB26luQ\"}},{id:3,path:\"./assets/img/video-community-thumb.jpg\",label:\"text0048\",url:{en:\"https://www.youtube.com/embed/-l4mUSPZWUI?rel=0\",zhcn:\"https://www.youtube.com/embed/DfiWbd8DZmg\"}},{id:4,path:\"./assets/img/video-vison-thumb.jpg\",label:\"text0049\",url:{en:\"https://www.youtube.com/embed/thFx7IndFR4?rel=0\",zhcn:\"https://www.youtube.com/embed/TrUoWc_7koE\"}},{id:5,path:\"./assets/img/video-regulatory-thumb.jpg\",label:\"text0050\",url:{en:\"https://www.youtube.com/embed/xXvdMVgl8aQ?rel=0\",zhcn:\"https://www.youtube.com/embed/XTtFZPs07-Q\"}}]},function(t,e,n){\"use strict\";t.exports=[{image:\"./assets/img/partners/idax.png\",url:\"https://www.idax.mn\"},{image:\"./assets/img/partners/eea.png\",url:\"https://entethalliance.org/members-2/\"},{image:\"./assets/img/partners/tidebit.png\",url:\"https://www.tidebit.com/\"},{image:\"./assets/img/partners/no-rest-labs.png\",url:\"http://norestlabs.com\"},{image:\"./assets/img/partners/identity-mind.png\",url:\"https://identitymindglobal.com/\"},{image:\"./assets/img/partners/coins-marketing.png\",url:\"http://www.coinsmarketing.com/\"},{image:\"./assets/img/partners/acticule.png\",url:\"http://acticule.com/\"},{image:\"./assets/img/partners/alpacian.png\",url:\"https://www.alpacian.com/\"},{image:\"./assets/img/partners/aptorum.png\",url:\"http://www.aptorumgroup.com/\"},{image:\"./assets/img/partners/ecovis.png\",url:\"https://www.ecovis.co.uk/\"},{image:\"./assets/img/partners/signate.png\"},{image:\"./assets/img/partners/tvm-china.png\"},{image:\"./assets/img/partners/videns.png\",url:\"http://videns-life.com/\"},{image:\"./assets/img/partners/ico101.png\",url:\"http://ico101podcast.com/\"},{image:\"./assets/img/partners/crypto101.png\",url:\"https://crypto101podcast.com/\"},{image:\"./assets/img/partners/tokenline.png\"}]},function(t,e,n){\"use strict\";t.exports=[{image:\"./assets/img/press/bloomberg.png\"},{image:\"./assets/img/press/business-insider.png\",url:\"http://markets.businessinsider.com/news/stocks/smart-capital-for-healthtech-startups-aenco-presents-the-world-s-first-blockchain-based-healthtech-financial-solutions-and-application-development-platform-1025138507\"},{image:\"./assets/img/press/morning-star.png\",url:\"https://www.morningstar.com/news/pr-news-wire/PRNews_20180523HK04256/smart-capital-for-healthtech-startups-aenco-presents-the-worlds-first-blockchainbased-healthtech-financial-solutions-and-application-development-platform.html\"},{image:\"./assets/img/press/dow-jones.png\"},{image:\"./assets/img/press/klse-malaysia.png\",url:\"https://ck5354.blogspot.com/p/pr-news-wire.html?rkey=20180523AE04256&filter=7336\"},{image:\"./assets/img/press/seeking-alpha.png\"},{image:\"./assets/img/press/marketwatch.png\"},{image:\"./assets/img/press/business-journals.png\",url:\"https://www.bizjournals.com/prnewswire/press_releases/2018/05/23/HK04256\"},{image:\"./assets/img/press/connect-web.png\"},{image:\"./assets/img/press/yahoo-finance.png\",url:\"https://sg.finance.yahoo.com/news/smart-capital-healthtech-startups-aenco-125300804.html\"},{image:\"./assets/img/press/healthcare-innovation.png\",url:\"https://www.enterpriseinnovation.net/article/worlds-first-blockchain-based-healthtech-financial-solutions-and-application-development?utm_source=silverpop&utm_medium=newsletter&utm_campaign=EI%20EGOV_ORG_health&mkt_tok=eyJpIjoiWVdSaE9UTTJObUZpTkdaaCIsInQiOiIrNTF2dExGSXVKMWxxblwvaGNUXC9lenNMTTRNcU5XK0dablNLcWlKYnQ3QUp0eWpIRjhzWnEyeEt0R3NwR1NtN0ZPdWlpcWZ6TkduY3RKcHpLeWJxRlkwWVRYQzFKblwvUnNnQzBDOHNZTmNtVWFNYjZybEJtcjQ5c3pBVjVcL0R6Vm4ifQ%3D%3D\"},{image:\"./assets/img/press/ihhr.png\",url:\"https://twitter.com/IHHRonline/status/1002191782719971328\"},{image:\"./assets/img/press/knbn.png\",url:\"http://www.newscenter1.tv/story/38257496/smart-capital-for-healthtech-startups-aenco-presents-the-worlds-first-blockchain-based-healthtech-financial-solutions-and-application-development\"},{image:\"./assets/img/press/fox-wflx.png\",url:\"http://www.wflx.com/story/38257496/smart-capital-for-healthtech-startups-aenco-presents-the-worlds-first-blockchain-based-healthtech-financial-solutions-and-application-development\"},{image:\"./assets/img/press/entrepreneur-magazine.png\",url:\"https://www.entrepreneur.com/article/314699\"}]},function(t,e,n){\"use strict\";t.exports={en:{text0001:\"AENCO IS THE WORLD’S FIRST HEALTHTECH FINANCIAL SOLUTIONS PLATFORM SUPPORTED BY THE AENCO BLOCKCHAIN\",text0002:\"HealthTech, Smart Capital, and Prime Brokerage Solutions Under One Umbrella\",text0003:\"PRIVATE SALE IS LIVE!\",text0004:\"JOIN NOW\",text0005:\"Eligible Contributors\",text0006:\"Learn More\",text0007:\"Bounty Program\",text0008:\"5% Referral Bonus\",text0009:\"WHITE PAPER\",text0010:\"TOKEN PAPER\",text0011:\"2 PAGER\",text0012:\"SLIDE PRESENTATION\",text0013:\"TEAM LAUNCH VIDEO\",text0014:\"WHAT IS AEN TOKEN?\",text0015:\"AEN Token Fuels and Facilitates an Ecosystem for HealthTech Entrepreneurialism, Innovation, and Research.\",text0016:\"The AEN token will be key building block and fuel that drives all financial transactions and medical utilities supported by Aenco’s blockchain and its financial solutions platforms. It will incentivise our ecosystem participants to engage in real impact transactions and innovative contributions to the community and network over time.\",text0017:\"GLOBAL COMMUNITY\",text0018:\"To enjoy platform membership, priority access to evolving ecosystem opportunities, utility, community rewards, and platform solutions.\",text0019:\"AENCO GLOBAL HEALTHTECH FINANCIAL SOLUTIONS\",text0020:\"Ecosystem opportunities and utility across three core application platforms: Aenco IB, Prime, and SmartCap Solutions.\",text0021:\"HEALTHTECH PARTNERS & SPONSORED PROJECTS\",text0022:\"Medical utility across an existing pipeline, and expanding network of HealthTech partners specializing in therapeutics, medical infrastructure, medical data analytics, and innovative forms of healthcare technology services.\",text0023:\"THE AENCO ECOSYSTEM SOLUTIONS\",text0024:\"AEN TOKEN\",text0025:\"Ecosystem Utility Membership Access\",text0026:\"AENCO IB SOLUTIONS\",text0027:\"ICO Integrity Program;\",text0028:\"AENX: Trading Exchange for HealthTech participants;\",text0029:\"Ongoing Research Coverage of issuers and data analytics for subscribers and issuers\",text0030:\"AENCO PRIME SOLUTIONS\",text0031:\"Aenco decentralized Prime Brokerage Platform\",text0032:\"AENCO SMARTCAP SOLUTIONS\",text0033:\"Technology Driven Digital Banking Platform for HealthTech industry\",text0034:\"Alternative Financing\",text0035:\"HEALTHTECH CHALLENGES\",text0036:\"Lack of a robust financial ecosystem for HealthTech innovations\",text0037:\"High entry barriers and burdensome hurdles in fundrasing\",text0038:\"Little options for start-ups requiring one-stop-shop smart capital solutions\",text0039:\"Lack of a credible, global-accredited standard for ICO best practices\",text0040:\"THE OPPORTUNITIES\",text0041:\"A pressing need for disruptive and sustainable medical innovations\",text0042:\"Growing demand for medical entrepreneurialism and technologies\",text0043:\"Ongoing needs for deep impact solutions, such as treatment and prevention of diseases\",text0044:\"The growing maturity of blockchain technologies has democratized fundrasing\",text0045:\"EXPLORE AENCO\",text0046:\"AENCO EXPLAINED\",text0047:\"TECHNOLOGY ROLLOUT\",text0048:\"OUR COMMUNITY\",text0049:\"OUR VISION\",text0050:\"REGULATORY LANDSCAPE\",text0051:\"MORE VIDEOS\",text0052:\"TOKEN ECONOMY\",text0053:\"SOFT CAP\",text0054:\"USD<br />15,000,000\",text0055:\"TARGET CAP\",text0056:\"USD<br />60,000,000\",text0057:\"ACCEPTED<br />CRYPTO\",text0058:\"BTC<br />ETH\",text0059:\"Token Symbol\",text0060:\"AEN\",text0061:\"Token Name\",text0062:\"AEN Coin\",text0063:\"Token Type\",text0064:\"ERC223\",text0065:\"USD Price per token at ICO Sale\",text0066:\"0.1 + bonus based on week number\",text0067:\"USD Price per token at Pre-ICO Sale\",text0068:\"0.1 + bonus based on participation size\",text0069:\"Total Token Supply\",text0070:\"4,000,000,000\",text0071:\"Tokens Being Sold\",text0072:\"600,000,000\",text0073:\"Tokens Unsold\",text0074:\"Allocated to Reserves for Mining Rewards\",text0075:\"Softcap on Token Sale (USD)\",text0076:\"$15,000,000\",text0077:\"Target Cap on Token Sale (USD)\",text0078:\"$60,000,000\",text0079:\"Accepted Crypto Assets\",text0080:\"BTC, ETH\",text0081:\"PRIVATE SALE\",text0082:\"(June/July 2018)\",text0083:\"Contact us at aencoin.com for more information\",text0084:\"PRE-ICO SALE\",text0085:\"(July/August 2018)\",text0086:\"Participation Size *\",text0087:\"Bonus Tokens\",text0088:\"> 15 ETH\",text0089:\"+50%\",text0090:\"> 5 ETH and ≤ 15 ETH\",text0091:\"+40%\",text0092:\"≥ 1 ETH and ≤ 5 ETH (min 1 ETH)\",text0093:\"+30%\",text0094:\"FOMO Offering: First 24 hours!\",text0095:\"Additional +5%\",text0096:\"ICO CROWD SALE\",text0097:\"(3Q 2018 Announcement)\",text0098:\"Week No.\",text0099:\"1\",text0100:\"+15%\",text0101:\"2\",text0102:\"+10%\",text0103:\"3\",text0104:\"+5%\",text0105:\"The ETH equivalent shall be calculated for BTC contributions for the purpose of bonus allocations (based on exchange rate at time of subscription).\",text0106:\"TOKEN DISTRIBUTION\",text0107:\"TOKEN ALLOCATION\",text0108:\"(% of total token supply)\",text0109:\"Total Token Supply 4,000,000,000 AEN\",text0110:\"50%\",text0111:\"Mining Rewards\",text0112:\"21%\",text0113:\"Retained by Company and Team\",text0114:\"15%\",text0115:\"Token Sale (excl. bonus allocations)\",text0116:\"14%\",text0117:\"Bonus Allocations (on token sale) & Incentive Programs\",text0118:\"USE OF PROCEEDS\",text0119:\"(% of softcap allocation)\",text0120:\"Tokens being sold 600,000,000 AEN\",text0121:\"40%\",text0122:\"Sponsorship and Financial Solutions Platform form HealthTech Partners\",text0123:\"30%\",text0124:\"Research, Technology Development and Roll Out, and Collaboration Research\",text0125:\"24%\",text0126:\"General Working Capital and Infrastructure Setup Capital Requirements\",text0127:\"3%\",text0128:\"Marketing and Distribution\",text0129:\"3%\",text0130:\"Legal and Compliance\",text0131:\"ROADMAP\",text0132:\"4Q 2010\",text0133:\"Assets managed by Aeneas deployed into health care private equity and direct investments\",text0134:\"2Q 2016\",text0135:\"Aeneas Group builds HealthTech partnership with Aptorum Group, a multi-disciplinary medical innovations platform based in HK\",text0136:\"3Q 2017\",text0137:\"Aeneas Capital initiates to expand its licenses with the SFC in HK to include dealing and advising in securities\",text0138:\"Aeneas expands partnerships with HealthTech companies specializing in neuro, infectious diseases, and robotic surgeary devices\",text0139:\"1Q 2018\",text0140:\"Aeneas Capital, LLC. established in New Jersey, U.S.A. to set up a FINRA regulated broker dealer (in progress)\",text0141:\"Aneas Group establishing a full-service banking license in Europe (in progress)\",text0142:\"2Q 2018\",text0143:\"T-2M\",text0144:\"June/July Initiate Private Sale\",text0145:\"Aeneas Capital granted expanded licenses by the SFC in HK to deal and advise in securities\",text0146:\"Community investors outreach\",text0147:\"T-1M\",text0148:\"July/August Initiate Pre-ICO Sale: Bonus scheme based on participation size\",text0149:\"ICO\",text0150:'ICO Crowd Sale: 3rd Quarter 2018 Announcement (\"T\")',text0151:\"ICO PUBLIC SALES\",text0152:\"WEEK 1: 15% Bonus\",text0153:\"WEEK 2: 10% Bonus\",text0154:\"WEEK 3: 5% Bonus\",text0155:\"WEEK 4 Public Sale starting: No Bonus\",text0156:\"POST-ICO\",text0157:\"4Q 2018\",text0158:\"T+2M\",text0159:\"Expand team: Developers\",text0160:\"T+3M\",text0161:\"1st pipeline HealthTech ICO launch\",text0162:\"Launch first generation smart wallet & infrastucture (AEN Connect)\",text0163:\"T+6M\",text0164:\"Second generation custodial wallet & escow services\",text0165:\"2nd pipeline HealthTech ICO launch\",text0166:\"T+9M\",text0167:\"3rd pipeline HealthTech ICO launch\",text0168:\"4Q 2019\",text0169:\"T+15M\",text0170:\"Second generation: AENX trading exchange\",text0171:\"2Q 2020\",text0172:\"T+21M\",text0173:\"Third generation: AENCO prime brokerage platform\",text0174:\"Ongoing service & expansion of pipeline HealthTech partners\",text0175:\"MEDIA COVERAGE\",text0176:\"OUR PARTNERS\",text0177:\"SHOW MORE\",text0178:\"OUR TEAM\",text0179:\"OUR ADVISORS\",text0180:\"ACCOUNT\",text0181:\"SIGN UP\",text0182:\"LOGIN\",text0183:\"\",text0184:\"\",text0185:\"Disclaimer\",text0186:\"Privacy Policy\",text0187:\"CONTACT US\",text0188:\"REGISTERED ADDRESS\",text0189:\"Vistra Corporate Services Centre<br />Ground Floor NPF Building <br />Beach Road, Apia, Samoa\",text0190:\"ENQUIRIES\",text0191:\"moon@aencoin.com\",text0192:\"JOIN US ON TELEGRAM\",text0193:\"JOIN OUR COMMUNITY\",text0194:\"2018 © Aenco Solutions Ltd - Global Health Blockchain Financial Solutions\",text0195:\"PRE-SALE STARTS IN:\",text0196:\"TEAM\",text0197:\"BLOG\",text0198:\"CONTACT\",text0199:\"DAYS\",text0200:\"HOURS\",text0201:\"MINUTES\",text0202:\"SECONDS\",text0203:\"How It Works\",text0204:\"Ecosystem Solutions\",text0205:\"Challenges & Opportunities\",text0206:\"FAQ\",text0207:\"WHITE PAPER\",text0208:\"Token Paper\",text0209:\"2 Pager\",text0210:\"Slide Presentation\",text0211:\"Roadmap\",text0212:\"Our Team\",text0213:\"Media Coverage\",text0214:\"Our Partners\",text0215:\"AEN TOKEN\",text0216:\"Explore Aenco\",text0217:\"Token Economy\",text0218:\"Token Distribution\",text0219:\"FAQ\",text0220:\"Blog\",text0221:\"ACCOUNT\",text0222:\"Sign Up\",text0223:\"Login\",text0224:\"WHITE PAPER\",text0225:\"AEN TOKEN\",text0226:\"ROADMAP\",text0227:\"LANGUAGE\",text0228:\"Aenco - Global HealthTech Blockchain Financial Solutions\",text0229:\"Successfully register and have your KYC verified to earn 50 FREE AEN tokens!\",text0230:\"Successfully refer other AEN token buyers to get +5% bonus tokens!\",text0231:\"- referral link on dashboard -\",text0232:\"Register and have your KYC verified to earn 50 FREE AEN tokens!  Refer other AEN token buyers to get +5% bonus tokens!\",text1001:\"FREQUENTLY ASKED QUESTIONS\",text1002:\"We have provided answers to common questions we have been asked below.\",text1003:\"What is Aenco?\",text1004:'Aenco is a \"one stop shop\" for the delivery of cutting edge institutional financing, prime brokerage, and smart capital solutions for the HealthTech industry, as well as a research and collaboration hub for healthcare companies and projects involved in the field of blockchain development.',text1005:\"Aenco will be combining its solutions platform and core financing ecosystem with the wider healthcare technology community, through the AEN token, as the key ecosystem building block and extensions across all its service and community deliveries.\",text1006:\"Check out our <a>Whitepaper</a> for more information.\",text1007:\"Do you accept other methods of contribution such as credit card?\",text1008:\"No. Bitcoin (BTC) and Ethereum (ETH) are the only accepted method of contribution as part of the token sale.\",text1009:\"Can I / How do I participate in the token sale?\",text1010:\"The token sale is currently on private sale phase.\",text1011:'We are not accepting contributions from residents of USA, Samoa, China, and OFAC sanctioned countries. For Hong Kong based contributors, you must qualify and provide wealth proof as a \"Professional Investor\" under the Hong Kong SFC Guidance and Rules.',text1012:\"What are the requirements to participate in the token sale?\",text1013:\"We require you to go through our Sign Up process. To acquire AEN tokens, we also require you to go through our KYC Verfication.\",text1014:\"Will you offer any early bird bonus?\",text1015:\"Yes, we do operate an early bird bonus for the private sale and the pre-sale period. Please refer to the community announcements or the token paper for details.\",text1016:\"Do you have any Bounty Program?\",text1017:\"Yes, we value your support and reward bounty AEN tokens for your efforts. Stay tuned for the announcement of the details on the Bounty Program.\",text1018:\"When will I receive my AEN tokens?\",text1019:\"AEN tokens will be allocated to you upon confirmation of contribution. The distribution date of the token will be after the ICO. The exact date will be announced soon. Depending on the stage of contribution, there will be lock up restrictions on the withdrawal.\",text1020:\"What are the smart contract address and details of AEN Tokens?\",text1021:\"Contract Address: 0x0bef619cf38cf0c22967289b8419720fbd1db9f7\",text1022:\"Total Supply: 4,000,000,000 AEN\",text1023:\"Other Details: <a>https://etherscan.io/token/0x0bef619cf38cf0c22967289b8419720fbd1db9f7</a>\",text2001:\"Summary of Token Sale Terms and Conditions\",text2002:\"The following shows the summary of information for the Aenco Token Sale such as the terms and conditions, schedule, and bonus details. For more information, please check out our <a>Token Economics paper</a> and <a>Token Sale Terms and Conditions</a>.\",text2003:\"Please feel free to ask us questions. We recommend posting your question on our Telegram Group: Aencoin Community.\",text2004:\"Schedule of Private Sale\",text2005:\"Private Sale\",text2006:\"Start:\",text2007:\"Now\",text2008:\"End Date:\",text2009:\"26th July 11:59 pm UTC time OR once the soft cap is met, under Aenco Management's discretion. Minimum Contribution: USD 20,000 equivalent of ETH or BTC.\",text2010:\"Minimum Contribution:\",text2011:\"USD 20,000 equivalent of ETH or BTC.\",text2012:\"Bonus:\",text2013:\"+60% AEN tokens\",text2014:\"Pre-Sale and Crowd Sale\",text2015:\"Please refer to our <a>Whitepaper</a> and <a>Token Economics</a> documents.\",text2016:\"Soft Cap for the token sale:\",text2017:\"USD 15,000,000\",text2018:\"Target Cap for the token sale is:\",text2019:\"USD 60,000,000\",text2020:\"The Token Price:\",text2021:\"Eligibility & Restrictions:\",text2022:\"You must read, understand and agree to the <a>Token Sale Terms and Conditions</a>.\",text2023:\"Register your details at: <a>https://signup.aencoin.com/register</a>.\",text2024:\"Provide your Identity and Address documents for Identity Verification (collectively known as Know Your Customer (KYC) documents)\",text2025:\"Restricted Individuals (Nationals or Residents of):\",text2026:\"United States of America (USA),\",text2027:\"Independent State of Samoa (Samoa)\",text2028:\"People's Republic of China\",text2029:\"OFAC Sanctioned Countries* <a>https://sanctionssearch.ofac.treas.gov/</a>\",text2030:\"For Hong Kong Residents:\",text2031:\"Proof of Identity: Passport or HKID\",text2032:\"Proof of Address: Utility Bill or Bank Statement within the last three months\",text2033:\"Proof of Wealth: 1 or combined statements indicating cash or equivalents, securities (excluding Real Estate) in excess of HKD 8 mil\",text2034:\"For Rest of World:\",text2035:\"Proof of Identity: Passport\",text2036:\"Proof of Address: Utility bill, bank statement within the last three months or valid driver's license with address.\",text2037:\"We would like to give thanks to our community for the continued support.\",text2038:\"Disclaimer: The last update is on the 26-06-2018. The information above may be subject to change.\",text2039:\"USD 0.10\",text:\"\",text3001:\"IAN HUEN\",text3002:\"Co-Founder\",text3003:\"Over 15 years of global asset management experience;\",text3004:\"Founder and Managing Director  of Aeneas Capital;\",text3005:\"Former U.S. Equity research analyst at Janus Capital;\",text3006:\"Financial adviser to sale of Seng Heng Bank to ICBC in 2007;\",text3007:\"Trustee board of Dr Stanley Ho Medical Development Foundation;\",text3008:\"Panelist and speaker at Euromoney, S&P and the Middle East Investment Summit (MEIS 2017);\",text3009:\"MA in Comparative and Public History, The Chinese University of Hong Kong;\",text3010:\"A.B. Economics, Princeton University and CFA Charterholder;\",text3011:\"Financier, calligrapher, and historian.\",text3012:\"DARREN LUI\",text3013:\"Co-Founder\",text3014:\"Co-Founder of Aptorum Group Limited, a biotech platform.\",text3015:\"Co-Founder of Aeneas Group;\",text3016:\"Former Founder and Director at Varengold Capital, a HK based regulated asset manager and prime broker;\",text3017:\"Former Director at Barclays Capital, Barclays Bank PLC. London, Singapore and New York offices.\",text3018:\"Qualified Chartered Accountant (ICAS) at Ernst & Young LLP(UK).\",text3019:\"CFA Charterholder.\",text3020:\"Associate of Chartered Institute of Securities & Investments.\",text3021:\"First Class Honours BSc in Biochemistry, Imperial College London.\",text3022:\"KENRICK H. FOK\",text3023:\"Chief Financial Officer\",text3024:\"Multi-asset investment management professional and investor;\",text3025:\"Over 14 years of alternative investment experience spanning across hedge funds, asset managers, and direct investments;\",text3026:\"Former Investment Director and Responsible Officer at Guardian Capital Management;\",text3027:\"Former Equity Portfolio Manager and Responsible Officer at Generali Investments Asia (Generali Group company);\",text3028:\"Former Portfolio Manager and Responsible Officer at MAPS Capital Management (Mirae Asset Financial Group company);\",text3029:\"CFA Charterholder\",text3030:\"Sc. B Engineering, Brown University.\",text3031:\"GEOFFREY TIPTON\",text3032:\"Chief Technology Officer\",text3033:\"Numerous years of product and software development experience in Asia.\",text3034:\"Blockchain application and digital asset enthusiast.\",text3035:\"Control Engineering and Robotics specialist.\",text3036:\"3 year tour of duty as a Paramedic in the British Armed Forces.\",text3037:\"Early years in Blackpool working behind the scenes on many theatre stage productions (e.g. John Inman, Tommy Steel, Genesis, Sad Cafe).\",text3038:\"Avid horse rider and motorcyclist.\",text3039:\"Life long member of the Aviation club where flying a Robinson 22 helicopter is the preferred choice of transport.\",text3040:\"CHARLES LAU\",text3041:\"Managing Director\",text3042:\"Over 17 years experience in financial industry, as senior management in European banks and founder of wealth management company.\",text3043:\"Former Managing Director at Varengold Hong Kong, where its parent company Varengold Bank AG is a German Private Bank listed in Hamburg.\",text3044:\"Former senior management at Credit Suisse Privilege, Credit Suisse Bank, Hong Kong.\",text3045:\"Founder and CEO of MCG Private Wealth, a Private-equity funded wealth management company based in Hong Kong.\",text3046:\"Master of Business Administration graduate with focus on applications of modelling and theories in the financial industry.\",text3047:\"ERICA CHAN\",text3048:\"Head of Wealth Management\",text3049:\"Over 15 years of experience in financial industry, as senior management in European banks and wealth management company;\",text3050:\"Head of Wealth Management at Aeneas Group, a technology driven financial services platform based in Hong Kong;\",text3051:\"Former Head of Wealth Management at Varengold Hong Kong, wholly owned by Varengold Bank AG, a German Private Bank listed in Hamburg;\",text3052:\"Former Senior Executive Vice President at Credit Suisse Privilege, Credit Suisse Banking Group;\",text3053:\"BA (Hon) in Public & Social Administration.\",text3054:\"NICK WAN\",text3055:\"Co-Investment Director\",text3056:\"Solid knowledge of real estate market dynamics;\",text3057:\"In-depth knowledge of different property asset classes;\",text3058:\"Diverse experience in various areas within real estate industry;\",text3059:\"Wide geographical exposure including Asia, Europe, and the US real estate markets;\",text3060:\"Former investment manager and Responsible Officer at New Century Asset Management Limited (manager of New Century REIT);\",text3061:\"Former investment & asset manager at Invesco Real Estate Investment Asia Pacific Limited, AIG Global Real Estate (Asia) LLC, and Mapletree Logistics Trust Management Limited;\",text3062:\"BBA in Finance and Management Science, Simon Fraser University.\",text3063:\"CALVIN POON\",text3064:\"Co-Investment Director\",text3065:\"Over 20 years of experience in real estate investment, development, asset management and project management;\",text3066:\"Diversified real estate experience in commercial, residential and hospitality sectors;\",text3067:\"Senior real estate management positions held in various public and private companies in Hong Kong and U.S.  Former Head of Project at Glory Century Limited; Investment Manager at Imperial Pacific International Holdings Limited; and Executive Director at Euro Properties;\",text3068:\"Licensed real estate broker in New York State;\",text3069:\"M.S. in Real Estate Investment and Asset Management, New York University;\",text3070:\"M.S. and B.S. in Civil Engineering, Columbia University.\",text3071:\"ALLY CHEUNG\",text3072:\"Head of Community Management\",text3073:\"Community builder in the blockchain space, bridging the gap between today’s reality and tomorrow’s possibility with a positive belief and strategic vision\",text3074:\"Community Manager at Monaco, one of the most successful token sale events to date\",text3075:\"Business Development Manager at Galileo Platforms, an InsurTech Blockchain startup for reinventing insurance\",text3076:\"Deep enthusiasm in Blockchain technology and the Cryptocurrency industry\",text3077:\"MBA graduate from HKUST Business School and exchange in NYU Stern School of Business, focused on Finance\",text3078:\"Avid traveler, music junkie and foodie at heart\",text3079:\"DAVID CAREY\",text3080:\"Senior Cloud Engineer\",text3081:\"Lead in Security Review and hardening of the United Nations back-end systems;\",text3082:\"CTO of Network-box Thailand keeping the country secure;\",text3083:\"Developed online marketing and lottery systems;\",text3084:\"Developer of Web based applications and systems;\",text3085:\"Independent Consultant for Online Streaming solutions;\",text3086:\"Cloud services manager and enabler for various solution Providers;\",text3087:\"Cloud provisioning, monitoring and security hardening.\",text3088:\"MICHELLE AU\",text3089:\"Creative Specialist\",text3090:\"Over 10 years experience in web, commercial graphic & packaging design;\",text3091:\"Former Packaging Design Supervisor (AD) at Capdase, HK;\",text3092:\"Former Packaging Design Lecturer at Raffles College of Design and Commerce, HK\",text3093:\"Years of experience in independent projects, worked with clients from various industries & platforms;\",text3094:\"B.A. in Digital Media Technology, Columbia College Chicago;\",text3095:\"Believes that good design comes from heart and limitless imagination;\",text3096:\"Fan of Dan Brown, loves sci-fi, mom of 3 cats.\",text3097:\"ISSAC CHEUNG\",text3098:\"Full Stack Developer\",text3099:\"Over 7 years experience focusing on software development, engineering roles , and mobile applications in gaming and retail application sectors;\",text3100:\"Former Senior Analyst Programmer at Derivco Hong Kong, an online web and mobile game developer;\",text3101:\"Former Software Engineer at Advanced Systems Information Technology, with experience in development of POS and ERP systems;\",text3102:\"Double Degree in Bachelor of Science (Honors) in Computing and Bachelor of Business Administration (Honors) in Management from The Hong Kong Polytechnic University.\",text3103:\"ISABELLA LAI\",text3104:\"Senior Director\",text3105:\"Over 12 years of experience in financial industry, as a Senior Director in European banking and wealth management;\",text3106:\"Senior Director at Aeneas group, a technology driven financial services platform based in Hong Kong;\",text3107:\"Former Senior Director at Varengold Hong Kong, wholly owned by Varengold Bank AG, a German Private Bank listed in Hamburg;\",text3108:\"Former senior principal relationship manager at Credit Suisse Privilege, Credit Suisse Banking Group;\",text3109:\"BBA (Fin) from Simon Fraser University, Canada\",text3110:\"TEDDY IP\",text3111:\"Senior Director\",text3112:\"Adept executive in financial industry with over 20 years of experience in global banks and corporations;\",text3113:\"Senior Director at Aeneas group, a technology driven financial services platform based in Hong Kong;\",text3114:\"Former International Banking Manager, Citibank Australia;\",text3115:\"Former Project Consultant, Coopers & Lybrand Associates (now known as PWC) in Hong Kong;\",text3116:\"Former General Manger (Investment) of CWC Limited, founded by Jardine Group and Temasek, Singapore for investment in China;\",text3117:\"MBA (CUHK), Master in Environmental Engineering (UNSW, Australia), Master and Bachelor degrees in Social Sciences (HKU)\",text3118:\"ANDY CHAN\",text3119:\"Head of Insurance\",text3120:\"CEO of PIBA Broker (2015 – present);\",text3121:\"Specialized in Property & Casualty Insurance;\",text3122:\"Former Marketing Manager at HWL International Holdings Limited, a member of CIB, focusing on Marketing Planning, Finance & Accounting, Legal Compliance, specialized in Property & Casualty Insurance;\",text3123:\"Former General Manager at Million Trend Limited – General Agent of MetLife Hong Kong;\",text3124:\"Former Agency Manager at MetLife Hong Kong, specializing in team building and sales management for life insurance.\",text3125:\"Extra Curriculum: “Certificate in Fitness Instruction” from Hong Kong Baptist University;\",text3126:\"AARON REGALA\",text3127:\"Business Analyst\",text3128:\"Blockchain technology investor;\",text3129:\"Formerly worked in retail banking;\",text3130:\"Computing enthusiast building finance analytics;\",text3131:\"Graduated with B Sc. Physics from University College London\",text3132:\"PROFESSOR DOUGLAS W. ARNER\",text3133:\"Senior Regulatory and Strategic Advisor\",text3134:\"Kerry Holdings Professor in Law at the University of Hong Kong (“HKU”);\",text3135:\"Director of HKU LLM in Compliance and Regulation;\",text3136:\"Senior Visiting Fellow of Melbourne Law School, University of Melbourne;\",text3137:\"Co-Founder and former Director of the Asian Institute of International Financial Law, Faculty of Law, HKU;\",text3138:\"Leading specialist in economic and financial law, regulation, and development;\",text3139:\"Co-Authored of editor of 15 books including “Reconceptualising Global Finance and its Regulation “ (Cambridge, 2016);\",text3140:\"PhD and LLM in banking and finance law from University of London (Queen Mary College).\",text3141:\"DR S.M. YIU\",text3142:\"Advisor\",text3143:\"Associate Professor in the Department of Computer Science at the University of Hong Kong;\",text3144:\"Research and areas of expertise are computer security, cryptography, bioinformatics;\",text3145:\"Published over 100 papers in journals and conferences - Google Scholar statistics: Citations (8627), h-index (41), i10-index (98);\",text3146:\"Experience in industrial projects with Huawei, Hong Kong Sanatorium & Hospital, Astri, and Bank of China;\",text3147:\"PhD in Computer Science, The University of Hong Kong;\",text3148:\"MS in Computer and Information Science, Temple University (USA);\",text3149:\"BSc in Computer Science, The Chinese University of Hong Kong.\",text3150:\"JEFF MARQUASS\",text3151:\"Advisor\",text3152:\"Director of HOYA Surgical Optics, a specialist provider of ophthalmologists with high-quality intraocular lenses for use in the treatment of cataracts for over 25 years;\",text3153:\"Former Vice President Business Development at Advanced First Aid Research, a medical device company focused on wound care product development;\",text3154:\"Former Managing Director at Vendor Management Consulting Asia, a boutique consulting firm connecting European medical devices, pharma, biotech, and FMCG companies with Asia;\",text3155:\"Master Business Administration, University of Melbourne.\",text3156:\"JULIAN TING\",text3157:\"Advisor\",text3158:\"Former General Manager at Innovative Diagnostics, a leading Asian pathology diagnostic group;\",text3159:\"Formerly worked at Grange Partners in Singapore, a family office backed institution focusing on Southeast Asian Private Equity;\",text3160:\"Formerly held positions at HSBC Private Wealth Solutions and ECM Libra Investment Bank;\",text3161:\"Masters in Business Administration (MBA) from Columbia Business School (Dean’s Honors); Private Equity Fellow;\",text3162:\"Bachelor of Laws – LLB (Hons) Programme from London School of Economics.\",text3163:\"DR KENNY YU\",text3164:\"Advisor\",text3165:\"Clinical Research Fellow at the Salford Royal NHS Foundation Trust in the UK;\",text3166:\"PhD at The University of Manchester – Faculty of Medical and Human Sciences – Stem Cell and Neurotherapies Laboratory;\",text3167:\"Key areas of research interests include Cancer Biology, Oncology, Cell Culture, Genetic Engineering, Neurosurgery, and Cancer Immunology;\",text3168:\"Neurosurgeon at The University of Manchester.\",text3169:\"DR WILLIAM WU\",text3170:\"Advisor\",text3171:\"Assistant Professor at the Department of Anesthesia and Intensive Care at The Chinese University of Hong Kong;\",text3172:\"Expert in molecular pharmacology and toxicology;\",text3173:\"Has published extensively in cancer biomarker diagnostics and novel therapeutics; Published more than 150 internationally recognized, peer-reviewed articles in top international journals, including Nature Communications, Autophagy, Cell Research, Cancer Research with an h-index of 40, and four book chapters;\",text3174:\"Earned his fellowship in the Royal College of Pathologists (FRCPath), and has been awarded the First-Class Higher Education Outstanding Scientific Research Output Award (Natural Science) by the Ministry of Education of China;\",text3175:\"PhD in Medical Sciences from CUHK and received post-doctoral training in the Institute of Digestive Diseases, CUHK afterwards.\",text3176:\"DR SUNNY WONG\",text3177:\"Advisor\",text3178:\"Assistant Professor in the Department of Medicine and Therapeutics at The Chinese University of Hong Kong;\",text3179:\"Principal investigator at the Li Ka Shing Institute of Health Science, the Institute of Digestive Disease and the State Key Laboratory of Digestive Disease;\",text3180:\"A clinician-scientist with expertise in host-microbe dynamics, in diseases including digestive cancers, mycobacterial and Clostridium difficile infections;\",text3181:\"Published 50+ peer-reviewed papers in top journals, including the New England Journal of Medicine and Nature Genetics;\",text3182:\"Investigator in multi-centered epidemiological studies, phase 2/3 drug trials.\",text3183:\"DR ALBERT LEUNG\",text3184:\"Advisor\",text3185:\"Financial and Business Development Consultant of Beauchamp International Development Limited based in Hong Kong;\",text3186:\"Former Assistant Vice President at Citicorp International in Hong Kong and engaging in major IPO corporate finance matters;\",text3187:\"10 years of experience in accounting and auditing in accounting firms in England between 1977 and 1987;\",text3188:\"Currently an Independent Non-Executive Director of various public companies listed on the Hong Kong Stock Exchange;\",text3189:\"Director of the Hong Kong Kidney Foundation;\",text3190:\"PhD (Economics), Shanghai University of Finance & Economics;\",text3191:\"MBA, Henley Business School , Brunel University (England);\",text3192:\"Member of the Hong Kong Institute of Certified Public Accountants.\",text3193:\"DR KWOK KA WAI\",text3194:\"Advisor\",text3195:\"Assistant Professor in the Department of Mechanical Engineering at The University of Hong Kong;\",text3196:\"Research focuses on image-guided robotic surgeries and their associated master-slave control interfaces;\",text3197:\"PhD in Computing from Imperial College London;\",text3198:\"BEng and MPhil degrees in Automation and Computer-Aided Engineering, The Chinese University of Hong Kong;\",text3199:\"Recipient of the Croucher Foundation Fellowship, which currently supported his postdoctoral research jointly hosted by University of Georgia, and Brigham and Women’s Hospital - Harvard Medical School.\",text3200:\"JOE HUI\",text3201:\"Advisor\",text3202:\"Investment Director, Quantitative Strategies, Eagle Eye Group;\",text3203:\"Guest speaker at the Institute for China Business, HKU Space;\",text3204:\"Guest speaker at HanQing Advanced Institute of Economics and Finance , Renmin University of China;\",text3205:\"Former Chief Investment Advisor of JLPAY China;\",text3206:\"Former quantitative investment consultant roles for Hong Kong and China funds;\",text3207:\"Former Senior Researcher Fellow at the Faculty of Engineering, The University of Hong Kong; Key research interests include quantitative finance, blockchain technologies, and artificial intelligence;\",text3208:\"Master of Finance, Tsinghua University (Beijing).\",text3209:\"DR OWEN KO\",text3210:\"Advisor\",text3211:\"Clinical Lecturer in the Department of Medicine and Therapeutics at The Chinese University of Hong Kong (“CUHK”);\",text3212:\"Published two first authored Nature papers and one first authored Nature Neuroscience paper;\",text3213:\"Bachelor of Medicine and Bachelor of Surgery Programme (MBChB) at CUHK in 2005. Bachelor of Medical Sciences (BMedSci) under the mentorship of Professor Wing-ho Yung in the School of Biomedical Sciences;\",text3214:\"PhD programme in Neuroscience at University College London (UCL) under the guidance of Professor Thomas Mrsic-Flogel. His breakthrough research has led to his Runner-up Award of the Eppendorf & Science Prize for Neurobiology as the first awardee in Hong Kong.\",text3215:\"SHELL CHUNG\",text3216:\"Advisor\",text3217:\"Security Consultant at Alpacian Limited, a Hong Kong based enterprise I.T. security firm;\",text3218:\"Information Security & Computer Forensics Specialist;\",text3219:\"Expertise in web & mobile application security assessment;\",text3220:\"Providing professional advisory to listed company or corporate in Information Security & Technical issues;\",text3221:\"Familiar with Information Security Risk Management framework, incident response & computer forensics investigations.\",text3222:\"DR KEVIN CHAN\",text3223:\"Advisor\",text3224:\"20 years of experience in finance and asset management;\",text3225:\"Currently a Managing Director at Cachet Asset Management, a firm that offers proprietary hedge funds, private equities, and direct investment opportunities for investors;\",text3226:\"Formerly a Managing Partner at Cornucopia Capital Partners;\",text3227:\"Has held positions at Goldman Sachs Asset Management in New York City, and Sparx Asset Management (Tokyo) as a Research and Quantitative Analyst;\",text3228:\"Holds dual degrees from the University of Pennsylvania in Management and Technology;\",text3229:\"PhD in Financial Economics from Massachusetts Institute of Technology.\",text3236:\"VIRGINIA LAM\",text3237:\"Marketing Advisor\",text3238:\"15 years of marketing experience in startups-turned-listed-companies; Passion for blockchain innovations;\",text3239:\"Co-Founder of COINS Marketing, a partner for fintech and blockchain projects;\",text3240:\"Head of Marketing at Xbrick, a global crypto currency exchange owned by X Blockchain Pty Ltd, a blockchain technology company headquartered in Sydney, Australia;\",text3241:\"Marketing Lead at The Abyss, a crypto reward ecosystem for gamers and developers;\",text3242:\"Co-Founder of V Partnership, a digital marketing agency;\",text3243:\"Former Marketing Director at Ensogo Limited (ASX: E88), operator of ecommerce businesses across Asia;\",text3244:\"BA – University of Sydney, English and Psychology.\",text3245:\"DOUGLAS CHING\",text3246:\"Marketing Advisor\",text3247:\"Over 20 years of marketing experience including digital marketing and social media marketing across the ecommerce and consumer electronics industries;\",text3248:\"Co-Founder of two marketing agencies under OOKEA Group: Coins Marketing (Token sale consultant agency) and V Partnership (Digital marketing agency);\",text3249:\"Former General Manager at Ensogo Limited (ASX:E88), established China headquarters;\",text3250:\"Qualified Google Analytics Individual; Cisco CCNA; Microsoft MCSE + MCDBA;\",text3251:\"Master of E-Commerce from Middlesex University, United Kingdom;\",text3252:\"BA – Economics, University of Toronto, Canada;\"},zhcn:{text0001:\"AENCO 是世界首个基于区块链的医疗科技金融解决方案平台\",text0002:\"医疗科技、智能资本和大宗经纪业务解决方案在一把伞下\",text0003:\"私人出售正在进行中！\",text0004:\"立即加入\",text0005:\"合格贡献者\",text0006:\"了解更多\",text0007:\"赏金计划\",text0008:\"5％推荐奖金\",text0009:\"白皮书\",text0010:\"代币纸\",text0011:\"2 页\",text0012:\"幻灯片演示\",text0013:\"团队发布视频\",text0014:\"什么是 AEN 代币？\",text0015:\"AEN 代为医疗科技创业、创新和研究提供便利并可促进生态系统。\",text0016:\"作为参与区块链开发的医疗保健公司的一站式解决方案提供商和研究协作中心，Aenco通过发布AEN代币将其解决方案平台和核心金融生态系统相结合，并作为所有服务和社区的关键构建块和扩展交付。\",text0017:\"全球业界\",text0018:\"享受平台会员资格，优先访问不断发展的生态系统机会、实用程序、社区奖励和平台解决方案。\",text0019:\"AENCO 全球融资解决方案\",text0020:\"三个核心应用平台的生态系统机遇和实用性：Aenco IB，大宗和智能资本解决方案。\",text0021:\"医疗科技伙伴<br />及未来的赞助项目\",text0022:\"整个现有渠道的医疗实用性，以及医疗科技合作伙伴网络的扩展，专门从事治疗、医疗基础设施、医疗数据分析和创新形式的医疗保健技术服务。\",text0023:\"AENCO 生态系统解决方案\",text0024:\"AEN 代币\",text0025:\"生态系统实用型 服务会员权限\",text0026:\"AENCO投行解决方案\",text0027:\"诚信 ICO 项目\",text0028:\"AENX: 医疗科技参与者的交易所\",text0029:\"持续的对发行人公司的研究覆盖、用户和发行人的数据分析\",text0030:\"AENCO 主经纪商解决方案\",text0031:\"AENCO 去中心化主经纪商平台\",text0032:\"AENCO 去中心化的主经纪商平台\",text0033:\"医疗科技行业的技术驱动数字银行平台\",text0034:\"另类融资\",text0035:\"医疗科技的挑战\",text0036:\"医疗科技创新缺乏强大的金融生态系统\",text0037:\"资金进入障碍高，资金筹措方面存在沉重的障碍\",text0038:\"初创企业几乎无任何选择，需要一站式智能资本解决方案\",text0039:\"缺乏可信，全球认可的 ICO 最佳实践标准\",text0040:\"机会\",text0041:\"迫切需要具有破坏性且可持续的医疗创新\",text0042:\"对医疗创业主义和技术的需求不断增长\",text0043:\"持续需要深层冲击解决方案，例如治疗和预防疾病\",text0044:\"区块链技术日益成熟，使筹资活动民主化\",text0045:\"探索 AENCO\",text0046:\"AENCO 解释\",text0047:\"技术推广\",text0048:\"我们的社区\",text0049:\"我们的愿景\",text0050:\"监管景观\",text0051:\"更多视频\",text0052:\"代币条款\",text0053:\"媒体报道\",text0054:\"美元<br />15,000,000\",text0055:\"众筹硬上限\",text0056:\"美元<br />60,000,000\",text0057:\"接受的<br />加密资产\",text0058:\"BTC<br />ETH\",text0059:\"代币符号\",text0060:\"AEN\",text0061:\"代币名称\",text0062:\"AEN Coin\",text0063:\"代币类型\",text0064:\"ERC223\",text0065:\"ICO 每代币美元价格\",text0066:\"0.1 + 基于周数的代币回赠\",text0067:\"海外 ICO 前每代币美元价格\",text0068:\"0.1 + 基于参与金额的代币回赠\",text0069:\"代币总供应\",text0070:\"4,000,000,000\",text0071:\"出售代币数量\",text0072:\"600,000,000\",text0073:\"未能售出的代币\",text0074:\"分配给采矿奖励的储备金\",text0075:\"众筹软上限 (美元)\",text0076:\"$15,000,000\",text0077:\"众筹硬上限 (美元)\",text0078:\"$60,000,000\",text0079:\"接受的加密资产\",text0080:\"BTC, ETH\",text0081:\"私人销售\",text0082:\"(2018年6月/7月)\",text0083:\"请致 aencoin.com 联系我们了解更多信息\",text0084:\"海外 ICO 前发售\",text0085:\"(2018年7月/8月)\",text0086:\"参与金额*\",text0087:\"代币回赠\",text0088:\"> 15 ETH\",text0089:\"+50%\",text0090:\"5 ETH 到 15 ETH\",text0091:\"+40%\",text0092:\"1 ETH 到 5 ETH (最少 1 ETH)\",text0093:\"+30%\",text0094:\"FOMO 发售：首24小时！\",text0095:\"额外 +5%\",text0096:\"海外 ICO 公开发售\",text0097:\"(2018年第三季度公告)\",text0098:\"周数\",text0099:\"1\",text0100:\"+15%\",text0101:\"2\",text0102:\"+10%\",text0103:\"3\",text0104:\"+5%\",text0105:\"BTC 的认购需换算为等价的 ETH 以分配奖金 (根据认购时的汇率)。\",text0106:\"代币分布\",text0107:\"代币分配\",text0108:\"(代币总供应的百分比)\",text0109:\"代币总供应 4,000,000,000 AEN\",text0110:\"50%\",text0111:\"掘矿奖励\",text0112:\"21%\",text0113:\"由公司和团队保留\",text0114:\"15%\",text0115:\"代币销售 (不含回赠分配)\",text0116:\"14%\",text0117:\"回赠分配 (代币销售) 及奖励计划\",text0118:\"募资用途\",text0119:\"(软上限的分配比重)\",text0120:\"出售代币数量 600,000,000 AEN\",text0121:\"40%\",text0122:\"提供予医疗科技合作伙伴的赞助和金融解决方案平台\",text0123:\"30%\",text0124:\"研究、开发和推出技术、研究合作\",text0125:\"24%\",text0126:\"一般营运资金和基础设施建设的资本要求\",text0127:\"3%\",text0128:\"市场营销与分销\",text0129:\"3%\",text0130:\"法务与合规\",text0131:\"路线图\",text0132:\"2010年第4季度\",text0133:\"艾纳斯管理的资产投放入医护私募股权基金及直接投资\",text0134:\"2016年第2季度\",text0135:\"艾纳斯集团与Aptorum集团建立医疗科技合作关系，Aptorum集团是以香港为基地的多领域医疗创新平台\",text0136:\"2016年第3季度\",text0137:\"艾纳斯资金向香港证券及期货事务监察委员会申请包括证券买卖及咨询牌照。\",text0138:\"艾纳斯和其他医疗科技公司建立合作关系。这些公司的专业领域包括神经疾病、传染病及手术机械人等工具\",text0139:\"2018年第1季度\",text0140:\"艾纳斯集团于美国新泽西州成立艾纳斯集团资金有限责任公司，申请受美国金融业监管局规管的全面银行牌照。(进行中)\",text0141:\"艾纳斯集团于欧洲申请提供所相关股务的银行牌照。(进行中)\",text0142:\"2018年第2季度\",text0143:\"T-2个月\",text0144:\"于6月/7月开始私人发售\",text0145:\"艾纳斯资本取得香港证券及期货事务监察委员会批出的证券买卖及咨询牌照牌照\",text0146:\"业界投资者推广\",text0147:\"T-1 个月\",text0148:\"于7月/8月开始海外Pre-ICO 认购， 并推出以参与比例决定的回赠计划\",text0149:\"海外ICO\",text0150:'海外ICO公开销售: 2018第3季 (\"T\") 开始公开发售',text0151:\"海外ICO开始公开发售\",text0152:\"第1周: 15% 回赠\",text0153:\"第2周: 15% 回赠\",text0154:\"第3周: 15% 回赠\",text0155:\"第4周开始公开发售: 没有回赠\",text0156:\"海外ICO 後\",text0157:\"2018第4季度\",text0158:\"T+2个月\",text0159:\"扩展团队：开发商\",text0160:\"T+3个月\",text0161:\"推出第一次医疗科技管道 海外ICO\",text0162:\"推出第一智能钱币及基建 (AEN Connect)\",text0163:\"T+6个月\",text0164:\"第二代保管及第三方托管服务\",text0165:\"推出第二次医疗科技管道 海外ICO\",text0166:\"T+9个月\",text0167:\"推出第三次医疗科技管道 海外ICO\",text0168:\"2019年第4季度\",text0169:\"T+15个月\",text0170:\"第二代： AENX 交易所\",text0171:\"2020年第2季度\",text0172:\"T+21个月\",text0173:\"第三代：AENCO 主经纪商平台\",text0174:\"持续服务及拓展医疗科技合作伙伴管道\",text0175:\"媒体报道\",text0176:\"我们的合作伙伴\",text0177:\"展示更多\",text0178:\"核心团队\",text0179:\"战略顾问及伙伴\",text0180:\"帐户\",text0181:\"注册\",text0182:\"登录\",text0183:\"\",text0184:\"\",text0185:\"免责声明\",text0186:\"隐私政策\",text0187:\"联系我们\",text0188:\"注册地址\",text0189:\"萨摩亚阿皮亚海滩路 <br />NPF大楼底层<br />Vistra公司服务中心\",text0190:\"查询\",text0191:\"moon@aencoin.com\",text0192:\"加入我们的TELEGRAM\",text0193:\"加入我们的社区\",text0194:\"2018©Aenco 解决方案有限公司 - 全球健康区块链金融解决方案\",text0195:\"海外 ICO前发售即将开始:\",text0196:\"团队\",text0197:\"博客\",text0198:\"联系我们\",text0199:\"天\",text0200:\"小时\",text0201:\"分钟\",text0202:\"秒\",text0203:\"怎么运行\",text0204:\"生态系统解决方案\",text0205:\"挑战与机会\",text0206:\"常见问题\",text0207:\"白皮书\",text0208:\"代币纸\",text0209:\"2 页\",text0210:\"幻灯片演示\",text0211:\"路线图\",text0212:\"团队\",text0213:\"媒体报道\",text0214:\"合作伙伴\",text0215:\"AEN 代币\",text0216:\"探索AENCO\",text0217:\"代币条款\",text0218:\"代币分布\",text0219:\"常见问题\",text0220:\"博客\",text0221:\"帐户\",text0222:\"注册\",text0223:\"登录\",text0224:\"白皮书\",text0225:\"AEN 代币\",text0226:\"路线图\",text0227:\"语言\",text0228:\"全球医疗科技区块链融资解决方案\",text0229:\"成功注册并经过KYC验证的用户可获得50个AEN代币奖励!\",text0230:\"成功推荐其他买家的用户可获得额外5％AEN代币奖励!\",text0231:\"- 推荐连结在仪表板中 -\",text0232:\"注册并经过KYC验证的用户可获得50个AEN代币奖励! 推荐其他买家的用户可获得额外5％AEN代币奖励!\",text1001:\"常见问题\",text1002:\"我们已经为下方提到的常见问题提供了答案。\",text1003:\"什么是 Aenco?\",text1004:\"Aenco是一个“一站式服务“，为医疗科技行业提供尖端机构融资、大宗经纪和智能资本解决方案，以及参与区块链开发领域的医疗保健公司和项目的研究和协作中心。\",text1005:\"Aenco将通过AEN代币将其解决方案平台和核心融资生态系统与更广泛的医疗技术社区相结合，作为其所有服务和社区交付的关键生态系统构建模块和扩展。\",text1006:\"查看我们的<a>白皮书</a>了解更多信息。\",text1007:\"你是否接受信用卡等其他贡献方式？\",text1008:\"不。作为代币销售的一部分，比特币 (BTC) 和以太坊 (ETH) 是唯一接受的贡献方式。\",text1009:\"我可以/如何参与代币销售？\",text1010:\"代币销售目前正处于私人销售阶段。\",text1011:\"我们不接受美国、萨摩亚、中国和 OFAC 受制裁国家的贡献。 对于香港的贡献者，你必须根据香港证监会指引及规则作为“专业投资者“具备资格并提供财富证明。\",text1012:\"参与代币销售的要求是什么？\",text1013:\"我们要求你完成注册过程。若 要获得 AEN 代币，我们还要求你通过我们的 KYC 验证。\",text1014:\"你提供任何早鸟奖金吗？\",text1015:\"是的，我们确实为私人销售和预售期间提供早鸟奖金。 有关详细信息，请参阅社区公告或代币文件。\",text1016:\"你提供任何赏金计划吗？\",text1017:\"是的，我们非常重视您的支持并奖励AEN代币赏金。 请继续关注赏金计划详情的公布。\",text1018:\"我什么时候能收到 AEN 代币？\",text1019:\"AEN代币将在确认捐款后分配给您。代币的分发日期将在海外 ICO之后。 具体日期即将公布。 根据贡献阶段，将对提款进行锁定限制。\",text1020:\"智能合同地址是什么及AEN代币的详细信息？\",text1021:\"合同地址：0x0bef619cf38cf0c22967289b8419720fbd1db9f7\",text1022:\"总供应量：4,000,000,000 AEN\",text1023:\"其它细节：<a>https://etherscan.io/token/0x0bef619cf38cf0c22967289b8419720fbd1db9f7</a>\",text2001:\"代币销售条款和条件摘要\",text2002:\"下是 Aenco 代币销售的信息摘要，如条款和条件、时间表和奖金详情。有关更多信息，请查看我们的<a>代币经济学论文</a>和<a>代币销售条款和条件</a>。\",text2003:\"请随时向我们提出问题。 我们建议在我们的 Telegram 讨论组中发布你的问题：Aencoin 社区。\",text2004:\"私人出售时间表\",text2005:\"私人出售\",text2006:\"开始：\",text2007:\"现在\",text2008:\"结束日期：\",text2009:\"7月26日 晚上 11:59 UTC 或实现软上限后，Aenco 管理可自行决定最低贡献量：相当于 20,000 美元的 ETH 或 BTC。\",text2010:\"最低贡献：\",text2011:\"相当于 20,000 美元的 ETH 或 BTC\",text2012:\"奖金：\",text2013:\"+ 60％AEN代币\",text2014:\"预售和众筹销售\",text2015:\"请参阅我们的<a>白皮书</a>和<a>代币经济学文件</a>。\",text2016:\"代币销售的软上限：\",text2017:\"15,000,000 美元\",text2018:\"代币销售的目标上限是：\",text2019:\"60,000,000 美元\",text2020:\"代币价格：\",text2021:\"资格和限制：\",text2022:\"您必须阅读、理解并同意<a>代币销售条款和条件</a>。\",text2023:\"在<a>https://signup.aencoin.com/register</a>注册你的详细信息。\",text2024:\"提供你的身份证明和地址文档 (统称为了解您的客户(KYC)文档)\",text2025:\"受限制个人 (国民或居民)\",text2026:\"美利坚合众国 (美国)\",text2027:\"独立的萨摩亚国 (萨摩亚)\",text2028:\"中华人民共和国\",text2029:\"OFAC 受制裁国家* <a>https://sanctionssearch.ofac.treas.gov/</a>\",text2030:\"香港居民\",text2031:\"身份证明：护照或香港身份证\",text2032:\"地址证明：最近三个月内的水电费账单或银行对账单\",text2033:\"财富证明：1 或现金或等价物、证券 (不包括房产) 超过 800 万港元的合并报表\",text2034:\"世界其他地区\",text2035:\"身份证明：护照\",text2036:\"地址证明：水电费账单，过去三个月内的银行对账单或带有地址的有效驾驶执照。\",text2037:\"我们要感谢社区为我们提供不断支持。\",text2038:\"免责声明：最新更新于 2018年6月26日。 以上信息可能会有所更改。\",text2039:\"0.10美元\",text:\"\",text3001:\"禤骏远\",text3002:\"联合创始人\",text3003:\"超过15年的全球资产管理经验；\",text3004:\"艾纳斯资本有限公司创始人兼总经理；\",text3005:\"前美国骏利投资公司职证劵分析员；\",text3006:\"2007年，中国工商银行收购澳门诚兴银行交易中之卖方财务顾问；\",text3007:\"何鸿燊博士医疗拓展基金会信托委员会成员；\",text3008:\"2017年欧元、标准普尔及中东投资峰会(MEIS 2017)座谈会嘉宾及演讲者；\",text3009:\"香港中文大学比较及公众史学文学硕士；\",text3010:\"美国普林斯顿大学经济学学士及特许金融分析师；\",text3011:\"金融家、书法家及历史学家。\",text3012:\"雷宏业\",text3013:\"联合创始人\",text3014:\"生物技术平台Aptorum Group Limited联合创始人。\",text3015:\"艾纳斯集团联合创始人；\",text3016:\"香港受监管资产管理公司及主要经纪商华金证券前任创始人兼董事；\",text3017:\"前巴克莱银行集团巴克莱资本伦敦、新加坡及纽约办事处董事;\",text3018:\"安永会计师事务所(英国)合资格特许会计师(苏格兰特许会计师公会);\",text3019:\"特许金融分析师;\",text3020:\"英国皇家保险学院副学士;\",text3021:\"伦敦帝国学院一级荣誉生物化学学士学位。\",text3022:\"霍君行\",text3023:\"财务总监\",text3024:\"专业多元资产投资管理及投资者；\",text3025:\"超过14年跨越对冲基金、资产管理及直接投资的另类投资经验；\",text3026:\"前佳信投资管理有限公司投资总监和负责人;\",text3027:\"前忠利投资亚洲(忠利集团公司)股票投资组合经理及负责人；\",text3028:\"前迈普斯资本管理公司(未来资产金融集团公司)投资组合经理及负责人；\",text3029:\"特许金融分析师;\",text3030:\"布朗大学工程学理学士。\",text3031:\"GEOFFREY TIPTON\",text3032:\"首席技术官\",text3033:\"拥有多年在亚洲从事产品和软件开发经验;\",text3034:\"区块链应用程序和数字资产爱好者;\",text3035:\"控制工程及机器人技术专家;\",text3036:\"在英国军队担任3年护理人员;\",text3037:\"早年在布莱克浦从事多项戏剧舞台作品(如约翰英曼、汤米钢铁、创世纪、悲伤咖啡馆)之幕后工作;\",text3038:\"狂热骑师及摩托车手;\",text3039:\"香港飞行总会终身会员，罗宾逊22型直升机为其交通工具首选。\",text3040:\"刘正杰\",text3041:\"总经理\",text3042:\"拥有超过17年金融行业经验，在欧洲多间银行担任高级管理人员及财富管理公司创始人;\",text3043:\"前华金香港总经理，其母公司华金银行是在汉堡上市的德国私人银行;\",text3044:\"香港瑞士信贷银行瑞士信贷特许管理公司前高级管理人员;\",text3045:\"总部位于香港的私募股权基金财富管理公司，德禧私人资本的创始人兼首席执行官;\",text3046:\"工商管理硕士毕业，专注于金融行业建模和理论应用。\",text3047:\"陈慧诗\",text3048:\"财富管理总监\",text3049:\"超过15年金融行业经验，在欧洲多间银行和财富管理公司担任高级管理人员；\",text3050:\"以香港为基地的技术驱动金融服务平台艾纳斯集团的财富管理总监；\",text3051:\"由曾在德国汉堡上市的德国私人银行华金银行全资拥有的华金香港前财富管理总监；\",text3052:\"前瑞士信贷银行瑞士信贷特许公司的高级执行副总裁；\",text3053:\"公共和社会行政学(荣誉)学士。\",text3054:\"温煦阳\",text3055:\"联合投资总监\",text3056:\"熟知房地产市场动态；\",text3057:\"深入了解不同房地产资产类别；\",text3058:\"房地产业各领域多元化经验；\",text3059:\"接触广泛地区的工作，包括亚洲、欧洲和美国房地产市场；\",text3060:\"新世纪资产管理有限公司前任投资经理及负责人(新世纪房地产投资信托基金经理)；\",text3061:\"景顺亞太房产投资管理有限公司、AIG全球房地产(亚洲)有限责任公司和丰树物流信托管理有限公司之前投资和资产经理;\",text3062:\"西蒙弗雷泽大学财务与管理科学工商管理学士学位。\",text3063:\"潘发本\",text3064:\"联合投资总监\",text3065:\"在房地产投资、开发、资产管理和项目管理方面拥有超过20年的经验；\",text3066:\"商业、住宅和酒店业多元化的房地产经验；\",text3067:\"曾担任香港及美国多间公众及私营公司之高级房地产管理职位。世纪光辉事业有限公司前项目主管；博华太平洋国际控股有限公司前投资经理；欧洲置业有限公司执行董事；\",text3068:\"纽约州持牌房地产经纪人；\",text3069:\"纽约大学房地产投资与资产管理专业硕士；\",text3070:\"哥伦比亚大学土木工程学硕士及学士。\",text3071:\"张雪玲\",text3072:\"社群运营主管\",text3073:\"区块链领域的社群建设者，以积极的信念和战略眼光填补今日现实与未来可能性之间的差距\",text3074:\"摩纳哥社群经理，迄今为止最成功的销售活动之一\",text3075:\"始创以保险科技区域链重整保费的伽利略平台业务开发经理\",text3076:\"对区块链技术和加密货币行业充满热情\",text3077:\"香港科技大学商学院工商管理学理学士及纽约大学斯特恩商学院交换生，专注于金融\",text3078:\"狂热旅行家、音乐爱好者和美食家\",text3079:\"DAVID CAREY\",text3080:\"高级云工程师\",text3081:\"领导安全审查和加强联合国后端系统；\",text3082:\"网络通泰国之首席技术官，保证国家安全；\",text3083:\"开发在线营销和彩票系统；\",text3084:\"基于Web的应用程序及系统的开发人员；\",text3085:\"在线流媒体解决方案的独立顾问；\",text3086:\"云服务经理和各种解决方案提供商推动者；\",text3087:\"云配置、监控和安全强化。\",text3088:\"区米雪\",text3089:\"创意专家\",text3090:\"10年以上网络、商业图形和包装设计经验；\",text3091:\"香港卡登仕前包装设计主管(AD);\",text3092:\"香港莱佛士设计与商业学院前包装设计讲师;\",text3093:\"多年独立项目经验，与来自不同行业和平台的客户合作；\",text3094:\"芝加哥哥伦比亚学院数字媒体技术文学士；\",text3095:\"相信优秀的设计源自心灵和不受限制的想象力；\",text3096:\"丹布朗的粉丝，喜欢科幻小说，养有3只猫。\",text3097:\"张家铭\",text3098:\"全栈工程师\",text3099:\"在游戏及零售应用范畴有7年以上的软件开发，工程角色和移动应用方面的经验；\",text3100:\"在线网络和手机游戏开发商Derivco Hong Kong的前高级分析师程序员；\",text3101:\"盈浩资讯科技前软件工程师，具有开发销售点软件和企业资源计划软件系统经验；\",text3102:\"香港理工大学计算机科学(荣誉)学士学位和管理学士学位(荣誉)双学位。\",text3103:\"黎凯莉\",text3104:\"高级总监\",text3105:\"超过12年金融业经验，担任欧洲银行及财富管理业务高级总监;\",text3106:\"香港技术型金融服务公司艾纳斯集团高级总监;\",text3107:\"曾担任德国汉堡上市私人银行华金银行旗下的华金香港之高级总监;\",text3108:\"曾担任瑞士信贷集团旗下的瑞士尊贵理财部之主要客户关系经理;\",text3109:\"加拿大西门菲莎大学工商管理(金融)学士。\",text3110:\"叶克绍\",text3111:\"高级总监\",text3112:\"超过20年国际银行及企业工作经验，善于在金融业经营管理;\",text3113:\"香港技术型金融服务公司艾纳斯集团高级总监;\",text3114:\"澳洲花旗银行前任国际银行经理;\",text3115:\"曾在香港担任永道会计师事务所(现名普华永道)项目顾问;\",text3116:\"由怡和集团和新加坡淡马锡共同投资于中国的CWC有限公司前总经理(投资);\",text3117:\"商业管理硕士(香港中文大学)、环境工程学硕士(澳大利亚新南威尔士大学)及社会科学硕士和学士(香港大学)。\",text3118:\"陈子明\",text3119:\"保险业务主管\",text3120:\"香港专业保险经纪协会首席执行官(2015年至今);\",text3121:\"专门从事财产和意外伤害保险;\",text3122:\"裕铭环球集团有限公司前任营销经理，该公司是香港保险顾问练会成员，专注于营销规划、财务与会计、法律合规，专门从事财产和意外伤害保险;\",text3123:\"大都会人寿香港总代理百万趋势有限公司前任总经理;\",text3124:\"大都会人寿的前代理经理，专门负责人寿保险团队建设和销售管理。\",text3125:\"额外课程：香港浸会大学“健身指导证书”。\",text3126:\"AARON REGALA\",text3127:\"业务分析师\",text3128:\"区块链技术投资者；\",text3129:\"曾在零售银行工作；\",text3130:\"建设财务分析计算爱好者；\",text3131:\"伦敦大学学院物理学理学士毕业。\",text3132:\"PROFESSOR DOUGLAS W. ARNER\",text3133:\"高级监管和战略顾问\",text3134:\"香港大学嘉里基金法学教授(“港大”);\",text3135:\"香港大学法学学士合规与监管主任;\",text3136:\"墨尔本大学墨尔本法学院高级访问学者;\",text3137:\"香港大学法律系亚洲国际金融法研究所联合创始人兼前董事;\",text3138:\"经济和金融法律、监管和发展领域的专家;\",text3139:\"合着了15本书的编辑，其中包括“Reconceptualising Global Finance and its Regulation”(剑桥，2016);\",text3140:\"伦敦大学(玛丽皇后学院)银行及金融法学博士及法学硕士。\",text3141:\"姚兆明博士\",text3142:\"顾问\",text3143:\"香港大学计算机科学系副教授；\",text3144:\"研究和专业领域是计算机安全，密码学，生物信息学；\",text3145:\"在期刊和会议上发表超过100篇论文 - 谷歌学术搜索统计：引文(8627), h指数(41), i10指数(98);\",text3146:\"有与华为、香港养和医院、香港应用科技研究院和中国银行在工业项目方面的经验；\",text3147:\"香港大学计算机科学哲学博士；\",text3148:\"美国坦普尔大学计算机与信息科学硕士；\",text3149:\"香港中文大学计算机科学学士。\",text3150:\"JEFF MARQUASS\",text3151:\"顾问\",text3152:\"HOYA Surgical Optics 董事，超过25年专为眼科医生提供在治疗白内障时用到的高素质人工晶体镜片；\",text3153:\"前任Advanced First Aid Research商务发展副主席，Advanced First Aid Research专门售卖医疗仪器，而且主要发展护理伤口的产品；\",text3154:\"前任Vendor Management Consulting Asia董事总经理。 Vendor Management Consulting Asia为一家小型咨询公司，与欧洲医疗仪器公司、制药公司、生物科技公司及亚洲快速消费品公司有联系；\",text3155:\"澳洲墨尔本大学企业经济学硕士。\",text3156:\"JULIAN TING\",text3157:\"顾问\",text3158:\"前任Innovative Diagnostics总经理，Innovative Diagnostics是一家于亚洲在病理学真知方面拥有领导地位的集团；\",text3159:\"曾在新加坡Grange Partners工作，该公司为家庭式机构，集中东南亚人民的私募股权投资事务；\",text3160:\"曾于香港上海汇丰银行私人汇财策划部及ECM Libra投资银行工作；\",text3161:\"哥伦比亚大学商学院企业经济学硕士(院长嘉许名单);私募股权投资研究员 ;\",text3162:\"伦敦政治经济学院法律学士学位。\",text3163:\"KENNY YU 博士\",text3164:\"顾问\",text3165:\"英国Salford皇家NHS信托基金会临床研究员；\",text3166:\"曼彻斯特大学博士学位 - 医学和人类科学学院 - 干细胞与神经疗法实验室；\",text3167:\"研究兴趣的重点领域包括癌症生物学、肿瘤学、细胞培养、基因工程、神经外科和癌症免疫学；\",text3168:\"曼彻斯特大学神经外科医生。\",text3169:\"胡嘉麒博士\",text3170:\"顾问\",text3171:\"香港中文大学麻醉与重症监护系助理教授；\",text3172:\"分子药理学和毒理学专家；\",text3173:\"广泛发表癌症生物标志物诊断和新疗法; 在Nature Communications，Autophagy，Cell Research，Cancer Research等国际顶级期刊上发表了超过150篇国际公认的同行评议文章，于Cancer Research 发表的文章的h指数为40，并着有四本书章；\",text3174:\"皇家病理学院院士(FRCPath)，并获中国教育部授予“一级高等教育杰出科学研究成果奖(自然科学)”;\",text3175:\"中大医学科学博士，之后在中大消化疾病研究所接受博士后培训。\",text3176:\"黄曦博士\",text3177:\"顾问\",text3178:\"香港中文大学医学与治疗学系助理教授;\",text3179:\"李嘉诚健康科学研究所、消化疾病研究所和消化疾病国家重点实验室首席研究员；\",text3180:\"临床科学家，专注于宿主微生物动力学方面、消化系统肿瘤，分枝杆菌和艰难梭菌感染等疾病；\",text3181:\"在顶级期刊包括“新英格兰医学杂志”和”自然遗传学”上发表了50多篇同行评议论文；\",text3182:\"跨中心流行病学研究，第2/3期药物试验的研究者。\",text3183:\"梁兆棋博士\",text3184:\"顾问\",text3185:\"标祥国际发展有限公司之财务及商业发展顾问;\",text3186:\"前任花旗银行国际有限公司为助理副总裁，参与大型首次公开募股的企业财务事宜;\",text3187:\"于1977年至1987年期间曾于英国多间会计师事务所累积10年之会计及审计经验;\",text3188:\"现时为多家香港交易所上市公司的独立非执行董事;\",text3189:\"香港肾脏基金会总监;\",text3190:\"中华人民共和国上海财经大学颁授之经济学博士;\",text3191:\"英国布鲁内尔大学工商管理学硕士;\",text3192:\"香港会计师公会会员;\",text3193:\"郭嘉威博士\",text3194:\"顾问\",text3195:\"香港大学机械工程系助理教授;\",text3196:\"主力研究影像引导机械人手术及相关主控/从属控制接口;\",text3197:\"伦敦大学帝国学院计算机博士学位;\",text3198:\"香港中文大学机械与自动化工程学系工程学士及硕士学位;\",text3199:\"获裘槎基金会颁发奖学金，资助其在乔治亚大学和哈佛医学院附属布莱根妇女医院共同主办的博士后研究\",text3200:\"许嘉铭\",text3201:\"顾问\",text3202:\"鹰眼集团计量策划部投资总监;\",text3203:\"香港大学专业进修学院中国商业学院客席讲师;\",text3204:\"中国人民大学汉青经济与金融高级研究院客席讲师;\",text3205:\"嘉联支付有限公司前首席投资顾问;\",text3206:\"曾于香港和中国多家基金会担任计量投资顾问;\",text3207:\"香港大学工程系前高级研究员，主要研究范畴包括计量金融、区块链技术和人工智能;\",text3208:\"北京清华大学金融学硕士.\",text3209:\"高浩博士\",text3210:\"顾问\",text3211:\"香港中文大学内科及药物治疗学系临床讲师;\",text3212:\"曾以第一作者身份于《自然》发表兩篇学术文章及于《自然神经科学》发表学术一篇文章;\",text3213:\"2005年在香港中文大学取得内外全科医学士学位。在容永豪教授的指导下完成生物医学学院医学科学学士;\",text3214:\"在Thomas Mrsic-Flogel教授的指导下于伦敦大学学院(UCL)完成神经科学完成博士课程。他的突破性研究使他荣获Eppendorf & Science颁发神经生物学奖，成为香港首位该奖的得奖者。\",text3215:\"SHELL CHUNG\",text3216:\"顾问\",text3217:\"香港电脑安全公司讯安顾问有限公司高级顾问;\",text3218:\"信息安全及电脑鉴证专家;\",text3219:\"拥有网络及流动应用程序保安审查的专门知识;\",text3220:\"为上市公司及企业提供信息安全及技术问题的专业建议;\",text3221:\"熟悉信息安全风险管理架构、突发事件应对及电脑鉴证调查.\",text3222:\"陈建玮博士\",text3223:\"顾问\",text3224:\"20年的财务和资产管理经验;\",text3225:\"目前担任Cachet Asset Management的董事总经理，该公司專为投资者提供专有对冲基金，私募股权和直接投资机会;\",text3226:\"曾任Cornucopia Capital Partners的管理合伙人;\",text3227:\"曾在纽约高盛资产管理公司和Sparx资产管理公司(东京)担任研究和定量分析师;\",text3228:\"拥有宾夕法尼亚大学管理和技术双学位;\",text3229:\"麻省理工学院金融经济学博士。\",text3236:\"VIRGINIA LAM\",text3237:\"市场顾问\",text3238:\"在初创上市公司有15年的营销经验; 对区块链创新的热忱；\",text3239:\"COINS Marketing的联合创始人，多个金融科技和区块链项目的合伙人；\",text3240:\"在Xbrick 担任营销主管。Xbrick 的总部位于澳大利亚悉尼，为区块链技术公司X Blockchain Pty Ltd拥有的全球加密货币交易所；\",text3241:\"对玩家和开发者的加密奖励生态系统The Abyss的营销主管；\",text3242:\"数字营销机构V Partnership的联合创始人；\",text3243:\"前跨亚电子商务运营商Ensogo Limited(ASX：E88)营销总监；\",text3244:\"悉尼大学英语和心理学文学士。\",text3245:\"DOUGLAS CHING\",text3246:\"市场顾问\",text3247:\"在电子商务和消费电子行业拥有超过20年的营销经验，包括数字营销和社交媒体营销；\",text3248:\"OOKEA集团旗下两个营销机构的联合创始人：COINS Marketing(代币销售顾问机构)和V Partnership(数字营销机构)；\",text3249:\"Ensogo Limited前任总经理(ASX：E88)并为其成立其中国总部；\",text3250:\"合资格的谷歌个人分析师；思科认证网络工程师; 微软认证系统工程师 + 微软认证资料库管理员；\",text3251:\"英国米德尔塞克斯大学电子商务硕士；\",text3252:\"加拿大多伦多大学经济学文学士；\"},kr:{text0001:\"AENCO는 세계 최초 블록체인-기반 건강 관리 금융 솔루션 플랫폼입니다\",text0002:\"건강 기술, 스마트 자금, 그리고 프라임 중개인 솔루션은 하나의 우산 아래 존재함\",text0003:\"사적 판매 시행 중!\",text0004:\"지금 가입하세요\",text0005:\"적절한 기여자\",text0006:\"더 알아보기\",text0007:\"바운티 프로그램\",text0008:\"5% 추천 보너스\",text0009:\"백서\",text0010:\"토큰 증서\",text0011:\"2 페이지\",text0012:\"슬라이드 발표\",text0013:\"팀 발사 비디오\",text0014:\"토큰은 무엇입니까?\",text0015:\"AEN 토큰 연료와 건강 기술 기업가 정신, 혁신 그리고 연구를 위한 에코시스템을 용이하게 한다.\",text0016:\"블록 체인 개발과 관련된 의료 회사들을 위한 원-스톱-상점 솔루션 제공 업체 및 연구 협력 허브인 Aenco는 AEN 토큰 출시를 통해 솔루션 플랫폼 및 핵심 금융 에코시스템을 모든 서비스와 커뮤니티에 핵심 빌딩 블록 및 확장 가능성으로 결합해 있습니다.\",text0017:\"글로벌 커뮤니티\",text0018:\"플랫폼 멤버십을 즐기시려면 진화하는 에코시스템 기회, 유틸리티, 커뮤니티 보상 그리고 플랫폼 솔루션에 우선적으로 권한을 받아보세요.\",text0019:\"AENCO 세계 보건 기술 솔루션\",text0020:\"에코시스템 기회 및 유틸리티가 세 가지 핵심 어플리케이션 플랫폼인: Aenco IB, 프라임 그리고 스마트캡 솔루션 전반에 있습니다.\",text0021:\"건강 기술 파트너<br />& 지원받은 프로젝트\",text0022:\"기존 파이프라인을 통해 의료 유틸리티 와 전문적인 치료, 의료 인프라, 의료 데이터 분석 그리고 혁신적인 의료 기술 서비스 형태의 건강 기술 파트너를 위한 네트워크 확장을 하고 있습니다.\",text0023:\"AENCO 에코시스템 솔루션\",text0024:\"AEN 토큰\",text0025:\"에코시스템 유틸리티 멤버십 권한\",text0026:\"AENCO IB 솔루션\",text0027:\"ICO 통합 프로그램;\",text0028:\"AENX: 건강 기술 참여를 위한 거래 교환;\",text0029:\"구독자와 발행자를 위한 발행자 그리고 데이터 분석의 지속적인 연구 범위\",text0030:\"AENCO 프라임 솔루션\",text0031:\"Aenco 분산 프라임 중개 플랫폼\",text0032:\"AENCO 스마트캡 솔루션\",text0033:\"건강 기술 산업을 위한 기술 주도형 디지털 은행 플랫폼\",text0034:\"대체 금융\",text0035:\"건강 기술 과제\",text0036:\"건강 기술 혁신을 위한 강력한 금융 에코시스템 부재\",text0037:\"모금 과정에서 높은 진입 장벽과 부담스러운 장애물 존재\",text0038:\"원-스톱-상점 스마트 자본 솔루션을 필요로 하는 신생 기업을 위한 옵션이 거의 없음\",text0039:\"ICO 모범 사례에 대한 신뢰할 수 있는 글로벌 인증 표준의 부제\",text0040:\"기회\",text0041:\"파괴적이고 지속 가능한 의료 혁신에 대한 절실한 필요\",text0042:\"의료 기업가 정신과 기술에 대한 수요 증가\",text0043:\"질병의 치료와 예방과 같은 심층적인 충격 솔루션에 대한 지속적인 요구\",text0044:\"블록 체인 기술의 성숙함은 모금을 민주화함\",text0045:\"AENCO 탐험\",text0046:\"AENCO 설명\",text0047:\"기술 공개\",text0048:\"커뮤니티\",text0049:\"비전\",text0050:\"규제력을 지는 풍경\",text0051:\"비디오 더 시청하기\",text0052:\"토큰 경제\",text0053:\"소프트 캡\",text0054:\"USD<br />15,000,000\",text0055:\"타겟 캡\",text0056:\"USD<br />60,000,000\",text0057:\"받아들여진<br />암호화\",text0058:\"BTC<br />ETH\",text0059:\"토큰 상징\",text0060:\"AEN\",text0061:\"토큰 이름\",text0062:\"AEN 코인\",text0063:\"토큰 유형\",text0064:\"ERC223\",text0065:\"ICO 판매에서 토큰 당 USD 가격\",text0066:\"주수에 따라 0.1+ 보너스 증정\",text0067:\"사전- ICO 판매에서 토큰 당 USD 가격\",text0068:\"참여 규모에 따라 0.1+ 보너스 증정\",text0069:\"총 토큰 공급량\",text0070:\"4000000000\",text0071:\"판매 중인 토큰\",text0072:\"600000000\",text0073:\"팔리지 않은 토큰\",text0074:\"채굴 보상을 위한 매장지에 할당\",text0075:\"토큰 판매에 소프트 캡 (USD)\",text0076:\"15000000\",text0077:\"토큰 판매에 타겟 캡 (USD)\",text0078:\"60000000\",text0079:\"암호화 자산이 허용됨\",text0080:\"BTC, ETH\",text0081:\"개인 판매\",text0082:\"(2018년 6월/7월)\",text0083:\"자세한 내용은 aencoin.com로 문의해주세요\",text0084:\"사전-ICO 판매\",text0085:\"(2018년 7월/8월)\",text0086:\"참가 규모*\",text0087:\"보너스 토큰\",text0088:\"> 15 ETH\",text0089:\"0.5\",text0090:\"> 5 ETH 그리고 ≤ 15 ETH\",text0091:\"0.4\",text0092:\"≥ 1 ETH 그리고 ≤ 5 ETH (최소 1 ETH)\",text0093:\"0.3\",text0094:\"FOMO 제공: 첫 24 시간!\",text0095:\"+5% 더함\",text0096:\"ICO 크라우드 판매\",text0097:\"(3Q 2018 알림)\",text0098:\"주수\",text0099:\"1\",text0100:\"0.15\",text0101:\"2\",text0102:\"0.1\",text0103:\"3\",text0104:\"0.05\",text0105:\"ETH 금액은 보너스 배정 목적의 BTC 기여도에 따라 계산됩니다 (구독 시점의 환율 기준으로 책정됨).\",text0106:\"토큰 유통\",text0107:\"토큰 할당\",text0108:\"(총 토큰 공급의 %)\",text0109:\"총 토큰 공급 4,000,000,000 AEN\",text0110:\"0.5\",text0111:\"채굴 보상\",text0112:\"0.21\",text0113:\"회사와 팀의 보유\",text0114:\"0.15\",text0115:\"토큰 판매 (보너스 할당 제외)\",text0116:\"0.14\",text0117:\"보너스 할당(토큰 판매시) & 인센티브 프로그램\",text0118:\"진행의 사용\",text0119:\"(소프트캡 할당의 %)\",text0120:\"토큰은 600,000,000 AEN이 판매됨\",text0121:\"0.4\",text0122:\"건강 기술 파트너를 위한 후원 및 금융 솔루션 플랫폼\",text0123:\"0.3\",text0124:\"연구, 기술 개발 및 롤아웃 그리고 공동 연구\",text0125:\"0.24\",text0126:\"갑기금 및 인프라 시설 설치 자본 요구 사항\",text0127:\"0.03\",text0128:\"마케팅과 유통\",text0129:\"0.03\",text0130:\"법률과 준수\",text0131:\"로드맵\",text0132:\"4Q 2010\",text0133:\"Aeneas가 관리하는 자산은 의료 보험 사모 펀드와 직접 투자로 배포됨\",text0134:\"2Q 2016\",text0135:\"Aeneas 그룹은 홍콩에 본사를 둔 다중 전문 의료 혁신 플랫폼인 Aptorum Group과 건강 기술 파트너십 체결함\",text0136:\"3Q 2017\",text0137:\"Aeneas 자본은 홍콩에서 SFC로 자격증 확장 개시, 증권 거래 그리고 자문 서비스를 포함합니다\",text0138:\"Aeneas는 신경, 감염성 질환 그리고 로봇 장치 전문 건강 기술 회사와 파트너십을 확대하고 있습니다\",text0139:\"1Q 2018\",text0140:\"Aeneas 자본, LLC는 미국 뉴저지에 설립되어 FINRA 규제 브로커 딜러를 설립 중에 있음 (진행 중)\",text0141:\"Aneas 그룹은 유럽에서 전체 서비스 은행의 자격을 구축 중에 있음 (진행 중)\",text0142:\"2Q 2018\",text0143:\"T-2M\",text0144:\"6월/7월 개인 판매 개시\",text0145:\"Aeneas 자본, 증권 거래 그리고 조언을 위해 홍콩 SFC의 자격증 확대 승인\",text0146:\"커뮤니티 투자자들의 지원 활동\",text0147:\"T-1M\",text0148:\"사전-ICO 판매 시작은 7월/8월: 참여 규모에 따른 보너스 계획\",text0149:\"ICO\",text0150:'ICO 크라우드 판매: 2018 3분기 공고 발표 (\"T\")',text0151:\"ICO 공공 판매\",text0152:\"1주차: 15% 보너스\",text0153:\"2주차: 10% 보너스\",text0154:\"3주차: 5% 보너스\",text0155:\"4주차 공공 판매 시작: 보너스 없음\",text0156:\"사후-ICO\",text0157:\"4Q 2018\",text0158:\"T+2M\",text0159:\"팀 확장: 개발자\",text0160:\"T+3M\",text0161:\"건강 기술의 1차 파이프라인 ICO 출시\",text0162:\"1세대 스마트 지갑 & 인프라 구축 (AEN 연결)\",text0163:\"T+6M\",text0164:\"2세대 보관 지갑 & 조건부 서비스\",text0165:\"건강 기술의 2차 파이프라인 ICO 출시\",text0166:\"T+9M\",text0167:\"건강 기술의 3차 파이프라인 ICO 출시\",text0168:\"4Q 2019\",text0169:\"T+15M\",text0170:\"2세대: AENX 교환 거래\",text0171:\"2Q 2020\",text0172:\"T+21M\",text0173:\"3 세대: AENCO 프라임 중개인 플랫폼\",text0174:\"파이프라인 건강 기술 파트너의 지속적인 서비스 & 확장\",text0175:\"매스컴 보도\",text0176:\"파트너들\",text0177:\"더 알아보기\",text0178:\"주요 팀원\",text0179:\"전략 고문 및 파트너\",text0180:\"계정\",text0181:\"가입하기\",text0182:\"로그인\",text0183:\"\",text0184:\"\",text0185:\"책임 부인\",text0186:\"개인 정보 정책\",text0187:\"문의하기\",text0188:\"등록된 주소\",text0189:\"Vistra 기업 서비스 센터<br />1층 NPF 빌딩, 비치 로드<br />아피아, 사모아\",text0190:\"조사\",text0191:\"moon@aencoin.com\",text0192:\"저희의 텔레그램에 가입하세요\",text0193:\"저희의 커뮤니티에 가입하세요\",text0194:\"2018 © Aenco 솔루션 Ltd – 글로벌 건강 블록체인 금융 솔루션\",text0195:\"이전 판매 시작 :\",text0196:\"팀\",text0197:\"블로그\",text0198:\"문의하기\",text0199:\"일\",text0200:\"시간\",text0201:\"의사록\",text0202:\"초\",text0203:\"어떻게 작동 하는가\",text0204:\"에코시스템 솔루션\",text0205:\"건강 기술 & 기회\",text0206:\"자주 묻는 질문\",text0207:\"白皮书\",text0208:\"토큰 증서\",text0209:\"2 페이지\",text0210:\"슬라이드 발표\",text0211:\"로드맵\",text0212:\"팀원\",text0213:\"매스컴 보도\",text0214:\"파트너들\",text0215:\"AEN 토큰\",text0216:\"AENCO 탐험\",text0217:\"토큰 경제\",text0218:\"토큰 유통\",text0219:\"자주 묻는 질문\",text0220:\"블로그\",text0221:\"계정\",text0222:\"가입하기\",text0223:\"로그인\",text0224:\"백서\",text0225:\"AEN 토큰\",text0226:\"로드맵\",text0227:\"언어\",text0228:\"세계적인 건강기술 블록체인 재정 솔루션\",text0229:\"성공적으로 등록하고 KYC를 확인한 사용자에게는 50 보너스 토큰을 보냅니다!\",text0230:\"다른 AEN 토큰 구매자를 성공적으로 추천 한 사용자에게 5 % AEN 보너스 토큰을 제공합니다!\",text0231:\"- 대시 보드의 추천 링크 -\",text0232:\"성공적으로 등록하고 KYC를 확인한 사용자에게는 50 보너스 토큰을 보냅니다! 다른 AEN 토큰 구매자를 성공적으로 추천 한 사용자에게 5 % AEN 보너스 토큰을 제공합니다!\",text1001:\"자주 묻는 질문\",text1002:\"아래에 제시된 일반적인 질문에 대한 답변을 제공했습니다.\",text1003:\"Aenco 는 무엇입니까?\",text1004:\"Aenco는 블록체인 개발 분야를 포함하여 건강 기술 업계를 위한 최첨단 기관 금융, 프라임 중개인 그리고 스마트 자본 솔루션은 물론건강 관리 그리고 의료 분야의 프로젝트와 연구를위한 허브 역할을 하고 있는 “원-스톱-상점”입니다.\",text1005:\"Aenco는 자사의 솔루션 플랫폼과 핵심 금융 에코시스템 AEN 토큰을 통한 광범위한 의료 기술 커뮤니티와 핵심 에코시스템 건설 블록 및 모든 서비스 및 커뮤니티 제공을 통한 확장으로 결합해 나갈 것입니다.\",text1006:\"더 많은 정보를 위해 저희의 <a>백서를</a> 확인해주세요.\",text1007:\"신용카드와 같은 다른 기부 방법을 받아들일 것입니까?\",text1008:\"비트코인 (BTC)과 이더리움 (ETH)는 토큰 판매의 일환으로 기여할 수 있는 유일한 수단입니다.\",text1009:\"토큰 판매에 참여할 수 있나요? 어떻게 하나요?\",text1010:\"토큰 판매는 현재 개인 판매 단계에 있습니다.\",text1011:\"우리는 미국, 사모아섬, 중국 그리고 OFAC 제재 대상 국가의 시민들의 기부금을 받지 않습니다. 홍콩을 기반으로 하는 기부자의 경우홍콩 SFC 지침과 규칙에 따라 “전문 투자자”로서의 자격을 증명해야 합니다.\",text1012:\"토큰 판매에 참여하기 위한 요구 사항은 무엇입니까?\",text1013:\"가입 절차가 필요합니다. AEN 토큰을 얻기 위해서는, KYC 인증을 통과해야 합니다.\",text1014:\"먼저 구매한 사람들에게 보너스가 제공됩니까?\",text1015:\"네, 개인 판매 및 사전-판매 기간에 조기 보너스를 제공합니다. 자세한 내용은 커뮤니티 발표 또는 토큰 뉴스를 참조해주세요.\",text1016:\"바운티 프로그램이 존재합니까?\",text1017:\"네, 저희는 당신의 노력에 대한 지지와 보상 바운티 AEN 토큰을 소중하게 생각하고 있습니다. 바운티 프로그램에 대한 세부 사항 발표를 듣기 위해 계속 지켜봐 주세요.\",text1018:\"언제 AEN 토큰을 받을 수 있나요?\",text1019:\"AEN 토큰은 기부 확인시 귀하에게 바로 배정됩니다. 토큰의 배포 날짜는 ICO 이후입니다. 정확한 날짜는 곧 발표될 것입니다. 기부 단계에 따라 회수에 대한 제한이 있을 것입니다.\",text1020:\"AEN 토큰의 스마트한 계약 주소 및 세부사항은 무엇입니까?\",text1021:\"계약 주소: 0x0bef619cf38cf0c22967289b8419720fbd1db9f7\",text1022:\"총 공급: 4,000,000,000 AEN\",text1023:\"기타 세부 정보: <a>https://etherscan.io/token/0x0bef619cf38cf0c22967289b8419720fbd1db9f7</a>\",text2001:\"토큰 판매 이용 약관 요약\",text2002:\"다음은 이용 약관, 일정, 그리고 보너스 세부 사항과 같은 Aenco 토큰 판매에 대한 요약 정보입니다. 자세한 <a>내용은 토큰 경제</a>와 <a>토큰 판매 이용 약관을 확인해주세요</a>.\",text2003:\"언제든지 저희에게 질문해주세요- 텔레그램 그룹: Aencoin 커뮤니티.\",text2004:\"개인 판매 일정\",text2005:\"개인 판매\",text2006:\"시작:\",text2007:\"지금\",text2008:\"종료일:\",text2009:\"7월 26일 오후 11시 59분 (UTC 시간) 또는 Aenco 관리의 판단에 따라 소프트 캡이 충족최소 기부금: ETH 또는 BTC에 상응하는 최소 USD 20,000\",text2010:\"최소 기부금\",text2011:\"ETH 또는 BTC에 상응하는 USD 20,000\",text2012:\"보너스:\",text2013:\"+60% AEN 토큰\",text2014:\"사전-판매 그리고 클라우드 판매\",text2015:\"<a>백서</a>와 <a>토큰 경제학</a> 문서를 참조하세요.\",text2016:\"토큰 판매를 위한 소프트 캡:\",text2017:\"USD 15,000,000\",text2018:\"토큰 판매를 위한 타켓 캡:\",text2019:\"USD 60,000,000\",text2020:\"토큰 가격:\",text2021:\"자격 & 제한 사항:\",text2022:\"귀하는 <a>토큰 판매 이용 약관을 읽고</a> 이해하고 동의해야 함.\",text2023:\"귀하의 세부 정보 등록: <a>https://signup.aencoin.com/register</a>.\",text2024:\"신원확인을 위해 신원과 주소 문서를 제공 (고객 문서 (KYC)라고 알려짐)\",text2025:\"제한된 개인 (국가 또는 거주자)\",text2026:\"미국 (USA)\",text2027:\"사모아 독립 국가 (Samoa)\",text2028:\"중화 인민 공화국\",text2029:\"OFAC 제재 대상 국가 * <a>https://sanctionssearch.ofac.treas.gov/</a>\",text2030:\"홍콩 거주민\",text2031:\"신분 증명: 여권 또는 HKID\",text2032:\"주소 증명: 지난 3개월 동안의 공과금 청구서 또는 은행 잔고 증명서\",text2033:\"부의 증명: 1또는 현금의 상당액을 나타내는 결합된 증명서, HKD 8백만을 넘는 유가 증권 (부동산 제외)\",text2034:\"세계 기타 지역\",text2035:\"신분증명서: 주소\",text2036:\"주소 증명: 지난 3개월 동안의 공과금 청구서, 은행 잔고 증명서 또는 유효한 운전면허증 주소\",text2037:\"지속적인 지원을 위해 저희 커뮤니티에 감사드리고 싶습니다.\",text2038:\"면책 조항: 마지막 업데이트는 2018년 6월 26일입니다. 위에 명시된 정보들은 변경될 수 있습니다.\",text2039:\"USD 0.10\",text:\"\",text3001:\"IAN HUEN\",text3002:\"공동 설립자\",text3003:\"15년 이상의 글로벌 자산 관리 경험;\",text3004:\"Aeneas 자산 설립자 그리고 전무 이사;\",text3005:\"Janus 자산의 전임 미국 주식 연구 분석가;\",text3006:\"2007년 Seng Heng 은행을 ICBC에 매각할 시기에 재정 고문;\",text3007:\"Stanley Ho 박사의 의료 발전 재단 이사회 이사;\",text3008:\"유로 머니, , S&P, 그리고 중동 투자 정상 회의 (MEIS 2017)의 패널리스트 및 강연자;\",text3009:\"비교 및 공적 역사의 MA, 홍콩의 중문 대학교;\",text3010:\"A.B. 경제, Princeton University그리고 CFA 창립자;\",text3011:\"금융가, 캘리그라퍼, 그리고 역사가.\",text3012:\"DARREN LUI\",text3013:\"공동 설립자\",text3014:\"Aptorum 유한 그룹 공동 설립자, 생명공학 플랫폼;\",text3015:\"Aeneas 그룹의 공동 설립자;\",text3016:\"Varengold 자산의 전임 설립자 및 이사, 홍콩 기반의 규제 자산 관리자이자 프라임 브로커;\",text3017:\"Barclays 자산, Barclays 은행 PLC. 런던, 싱가포르, 그리고 뉴욕 사무소의 전임 이사.\",text3018:\"Ernst & Young LLP(영국) 공인 회계사 (ICAS);\",text3019:\"CFA 설립자;\",text3020:\"안전 & 투자의 공인 기관;\",text3021:\"런던 Imperial College의 생화학과에서 BSc를 1등급으로 수여함.\",text3022:\"KENRICK H. FOK\",text3023:\"최고 재무 책임자 (CFO)\",text3024:\"다중 자산 투자 관리 전문가 및 투자자;\",text3025:\"해지 펀드, 자산 관리자 그리고 직접투자와 같은 대안투자 경험을 14년동안 쌓음;\",text3026:\"구제 자산 관리 오피스의 전임 투자 이사 및 책임자;\",text3027:\"Generali 투자 아시아 (Generali 그룹 회사)의 전임 자본 포트폴리오 매니저 및 책임 감독관;\",text3028:\"MAPS Capital Management의 전 포트폴리오 관리자 겸 책임자 (미래에셋 금융 그룹 회사);\",text3029:\"CFA 설립자;\",text3030:\"Sc. B 공학 기술, Brown University.\",text3031:\"GEOFFREY TIPTON\",text3032:\"최고 기술 책임자\",text3033:\"아시아에서 수년간 제품 및 소프트웨어 개발 경험을 가지고 있음;\",text3034:\"블록체인 어플리케이션과 디지털 자산 애호가;\",text3035:\"제어 공학과 로봇 전문가;\",text3036:\"영국 군대 응급 구조사로서 3년간 활동함;\",text3037:\"블랙풀에서 초기 몇 년간 다수의 연극 무대 제작 (예를 들어, John Inman, Tommy Steel, Genesis, Sad Cafe);\",text3038:\"열렬한 승마인과 오토바이 운전자;\",text3039:\"선호하는 운송 수단인 Robinson 22 헬리콥터를 타는 항공 클럽의 평생 회원.\",text3040:\"CHARLES LAU\",text3041:\"상무 이사\",text3042:\"유럽 은행의 고위 간부 및 자산 관리 회사 설립자로서 금융 업계에서 17년 이상 경험을 가지고 있음;\",text3043:\"Varengold 홍콩의 전무이사, Varengold 은행 AG는 함부르크에 상장된 독일 개인 은행;\",text3044:\"홍콩의 Credit Suisse Privilege, Credit Suisse 은행의 전임 고위 간부;\",text3045:\"홍콩에 본사를 둔 MCG 사모 펀드 자산 관리 회사에 MCG 설립자 및 CEO;\",text3046:\"금융 산업 모델링 및 이론 응용 분야에 중점을 둔 경영학 석사를 졸업함.\",text3047:\"ERICA CHAN\",text3048:\"자산 관리 책임자\",text3049:\"유럽 은행 및 자산 관리 회사의 고위 경영진으로서, 15년 이상 금융 업계 경력을 가지고 있음;\",text3050:\"홍콩에 기반을 둔 기술 주도 금융 서비스 플랫폼인 Aeneas 그룹의 자신 관리 책입자;\",text3051:\"함부르크에 상장된 독일 개인은행인 Varengold 은행 AG가 전적으로 소유하고 있는 Varengold 홍콩의 전임 자산관리 이사;\",text3052:\"Credit Suisse Privilege, Credit Suisse 은행 그룹의 전임 수석 부사장;\",text3053:\"공공 & 사회 행정 학사 BA (Hon).\",text3054:\"NICK WAN\",text3055:\"공동 투자 이사\",text3056:\"부동산 시장 역학에 대한 확실한 지식;\",text3057:\"다른 자산 클래스에 대한 심층적인 지식;\",text3058:\"부동산 업계의 다양한 분야에서의 경험;\",text3059:\"아시아, 유럽 및 미국 부동산 시장을 포함한 광범위한 지리적 노출;\",text3060:\"New Century 자산 관리 유한책임 회사 (New Century REIT의 매니저)의 전임 투자 관리자 및 책임자;\",text3061:\"Invesco 부동산 투자 아시아 태평양 유한회사, AIG 글로벌 부동산 (아시아) LLC, 그리고 Mapletree 물류 신탄 관리 유한회사의 전임 투자 & 자산 매니저;\",text3062:\"BBA 재무 및 경영 과학, Simon Fraser University.\",text3063:\"CALVIN POON\",text3064:\"공동 투자 이사\",text3065:\"부동산 투자, 개발, 자산 관리 및 프로젝트 관리 분야에서 20년 이상 경험;\",text3066:\"상업, 주거 및 환대 부문에서 다양화된 부동산 경험;\",text3067:\"홍콩 및 미국의 다양한 공공 및 민간 회사에서 수석 부동산 관리 직책을 맡았습니다. Glory Century Limited의 전임 프로젝트 책임자 이며; Imperial Pacific International Holdings Limited의 투자 매니저; 그리고 Euro Properties의 전무 이사;\",text3068:\"뉴욕주에서 라이선스를 가진 부동산 중개인;\",text3069:\"뉴욕 대학교 부동산 투자 및 자산 관리 석사;\",text3070:\"콜롬비아 대학교 토목 공학과 석사 및 박사.\",text3071:\"ALLY CHEUNG\",text3072:\"커뮤니티 관리 책임자\",text3073:\"긍정적인 믿음과 전략적 비전을 가지고 오늘날의 현실과 내일의 가능성 사이의 격차를 해소하는 블록 체인 공간의 커뮤니티 제작자;\",text3074:\"가장 성공적인 토큰 판매 이벤트중 하나인 모나코의 커뮤니티 관리자;\",text3075:\"보험 재투자를 위한 신생기업인 InsurTech 블록 체인과 Galileo Platforms의 사업 개발 매니저;\",text3076:\"블록 체인 기술 및 암호화 화폐 업계에 대한 깊은 열정이 있음;\",text3077:\"HKUST 비즈니스 학교에서 MBA 졸업, NYU Stern 비즈니스 학교에서 금융학 전공;\",text3078:\"열렬한 여행자, 음악 중독자, 그리고 미식가.\",text3079:\"DAVID CAREY\",text3080:\"수석 클라우드 기술자\",text3081:\"UN의 백엔드 시스템 보안 검토 및 강화를 지휘;\",text3082:\"국가를 안전하게 지키는 네트워크-박스 태국의 CTO;\",text3083:\"온라인 마케팅 및 추천 시스템 개발;\",text3084:\"웹 기반 어플리케이션과 시스템 개발자;\",text3085:\"온라인 스트리밍을위한 독립 컨설턴트해결책;\",text3086:\"다양한 솔루션 공급을 위한 클라우드 서비스 관리자 및 구현자;\",text3087:\"클라우드 권한 설정, 모니터랑 및 보안 강화.\",text3088:\"MICHELLE AU\",text3089:\"크리에이티브 전문가\",text3090:\"웹, 상업용 그래픽 & 패키지 디자인 분야에서 10년 이상 경험;\",text3091:\"Capdase, 홍콩의 전임 패키징 디자인 책임자 (AD);\",text3092:\"홍콩의 Raffles College에서 상업 디자인, 포장 디자인 전임 강사\",text3093:\"다양한 산업 및 플랫폼에 고객과 함께 독립 프로젝트를 진행한 수년간의 경력;\",text3094:\"시카고의 Columbia College에서 디지털 미디어 기술 B.A. 학위 취득함;\",text3095:\"좋은 디자인은 마음과 무한한 상상력에서 오는 것이라고 믿음;\",text3096:\"Dan Brown의 팬, 공상 과학 선호함, 그리고 3마리 고양이의 엄마.\",text3097:\"ISSAC CHEUNG\",text3098:\"풀 스택 개발자\",text3099:\"게임 및 소매 어플리케잉션 분야에서 소프트웨어 개발, 엔지니어링 역할 그리고 모바일 어플리케이션에 중점을 둔 7년 이상의 경험;\",text3100:\"Derivco 홍콩의 전임 수석 분석가 개발자, 온라인 웹 그리고 모바일 게임 개발자;\",text3101:\"POS 시스템 및 ERP 시스템 개발 경험이 있는 첨단 시스템 정보 기술의 전임 소프트웨어 엔지니어;\",text3102:\"홍콩 Polytechnic 대학교에서 이학 학사 (우등생) 그리고 컴퓨터 및 경영학 학사 학위 (우등생) 복수 전공.\",text3103:\"ISABELLA LAI\",text3104:\"수석 이사\",text3105:\"유럽 금융 및 자산 관리 담당 수석 이사로, 12년간 금융 업계 경력;\",text3106:\"홍콩에 기반을 둔 기술 주도 금융 서비스 플랫폼인 Aeneas 그룹의 수석 이사;\",text3107:\"함부르크에 상장된 독일 개인 은행인 Varengold 은행 AG가 전액 출자한 Varengold 홍콩의 전임 이사;\",text3108:\"Credit Suisse Privilege, Credit Suisse 은행 그룹의 전임 고위 주체자 관계 매니저;\",text3109:\"캐나다의 Simon Fraser University에서 BBA (Fin) 전공.\",text3110:\"TEDDY IP\",text3111:\"수석 이사\",text3112:\"글로벌 은행 및 기업에서 20년 넘는 경험을 지니고 있는 금융 업계 전문가;\",text3113:\"홍콩에 기반을 둔 기술 주도 금융 서비스 플랫폼인 Aeneas 그룹의 수석 이사;\",text3114:\"호주 시티은행의, 전임 국제 은행 매니저;\",text3115:\"홍콩 Coopers & Lybrand Associates에서 전임 프로젝트 컨설턴트 (PWC로 알려져 있음);\",text3116:\"싱가포르에 Jardine 그룹과Temasek이 중국 투자를 위해 설립한 CWC 우한회사의 전임 일반 매니저 (투자);\",text3117:\"MBA (CUHK), 환경 공학 석사 (UNSW, 호주), 사회 과학 학사 및 석사 (HKU).\",text3118:\"ANDY CHAN\",text3119:\"보험회사 대표\",text3120:\"PIBA 브로커의 CEO (2015 – 현재);\",text3121:\"재산 및 상해 보험 전문;\",text3122:\"HWL 국제 보험 유한회사의 전임 마케팅 매니저, CIB의 회원, 마케팅 계획 중심, 금융 & 회계, 법률 준수, 재산 & 사고 보험 전문;\",text3123:\"Million Trend 유한회사 전임 총괄 매니저 – MetLife 홍콩의 총 대리인;\",text3124:\"MetLife 홍콩의 전임 단일 관리자, 생명 보험 팀 구축 및 판매 관리 전문;\",text3125:\"추가 교과 과정: 홍콩 Baptist University에서 “건강 수련 자격증” 획득.\",text3126:\"AARON REGALA\",text3127:\"비즈니스 분석가\",text3128:\"블록체인 기술 투자자;\",text3129:\"전에 소매 은행에서 근무함;\",text3130:\"열광적인 건물 금육 분석 작업가;\",text3131:\"런던 대학교에서 물리학 학사 졸업.\",text3132:\"PROFESSOR DOUGLAS W. ARNER\",text3133:\"수석 규제 담당 및 전략 고문\",text3134:\"홍콩 대학교(“HKU”) 법학과 Kerry Holdings 교수;\",text3135:\"HKU LLM 규정 준수 및 규제 담당 이사;\",text3136:\"맬버른 대학교 맬버른 법대 수석 객원 연구원;\",text3137:\"HKU 법학부 아시아 금융 연구원 공동 창립자 및 전무 이사;\",text3138:\"경제 및 금융법, 규제 및 개발 분야의 대표 전문가;\",text3139:\"“재개념화 글로벌 금융 및 규제” (Cambridge, 2016) 등 15권 이상의 공동 집필가;\",text3140:\"런던 대학교 (Queen Mary College)에서 은행 및 금융 법학 석사 및 법학 박사.\",text3141:\"DR S.M. YIU\",text3142:\"고문관\",text3143:\"홍콩 대학교 컴퓨터과 부교수;\",text3144:\"연구 및 전문 분야는 컴퓨터 보안, 암호화 그리고 생물 정보학;\",text3145:\"저널 및 컴퍼런스에 100개 이상의 논문 발표 – 구글 학술 통계: 인용 (8627), h-index (41), i10-index (98);\",text3146:\"화웨이, 홍콩 요양소 & 병원, 아스트리 그리고 중국 은행과의 산업 프로젝트 경험;\",text3147:\"홍콩 대학교 컴퓨터 공학 박사;\",text3148:\"Temple University (USA)에서 컴퓨터 및 정보 과학 석사;\",text3149:\"홍콩 중문 대학에서 컴퓨터 과학 학사.\",text3150:\"JEFF MARQUASS\",text3151:\"고문\",text3152:\"HOYA Surgical Optics의 이사, 25년 이상의 백내장 치료를 위한 고품질 인공 수정체 렌즈를 전문적으로 시술하고 잇는 안과 전문의;\",text3153:\"상처 치료 제품 개발에 중점을 둔 의료 기기회사인 Advanced First Aid Research의 비즈니스과의 전임 부사장;\",text3154:\"유럽의 의료 장비, 제약, 생명 공학 그리고 FMCG 회사와 아시아를 연결하는 부티크 컨설팅 회사인 Vendor Management Consulting Asia의 전무 이사;\",text3155:\"맬버른 대학교에서 경영학 석사.\",text3156:\"TING\",text3157:\"고문\",text3158:\"아시아의 병리학 진단 그룹인 Innovative Diagnostics의 전임 총괄 매니저\",text3159:\"이전에 동남아시아 사모 펀드에 중점을 둔 가족 사무실 지원 기관인 싱가포르의 Grange Partners에서 근무함;\",text3160:\"HSBC Private Wealth Solutions 그리고 ECM Libra 투자 은행에서 근무함;\",text3161:\"Columbia Business School에서 경영학 석사 (MBA) (우등생); 사모 펀드;\",text3162:\"법률 학사 - London School of Economics에서 LLB (Hons) 프로그램 졸업.\",text3163:\"DR KENNY YU\",text3164:\"고문\",text3165:\"영국 Salford Royal NHS Foundation Trust의 임상 연구원;\",text3166:\"Manchester University에서 PhD – 의학 및 인문 과학- 줄기 세포 및 신경 요법 연구;\",text3167:\"관심 연구 분야는 암 생물학, 종양학, 세포 배양, 유전 공학, 신경 외과학, 암면역학 등이 있음;\",text3168:\"Manchester University의 신경외과 의사.\",text3169:\"DR WILLIAM WU\",text3170:\"고문\",text3171:\"홍콩 중화 대학 마취과 그리고 중환자실 부교수;\",text3172:\"분자 약리학 및 독물학 전문가;\",text3173:\"암 생물 마커 진단 및 신규 치료법에대해 광범위하게 발표함 (Nature Communications, Autophagy, Cell Research, Cancer Research, h-index of 40을 가진 암 연구 및 4 단원);\",text3174:\"Royal College에서 병리학자 (FRCPath) 연구원으로 중국 교육 일부를 통해 최상급 과학 연구 성과상을 수상함 (Natural Science);\",text3175:\"CUHK에서 의학 과학 박사 학위를 취득한 후 CUHK소아 과학 연구원에서 박사 취득 후에 교육 받음.\",text3176:\"DR SUNNY WONG\",text3177:\"고문\",text3178:\"홍콩 중문 대학교 의대와 치료학과 조교수;\",text3179:\"Li Ka Shing 건강 과학 연구소의 연구 소장, 소화기 연구 및 소화 질병에 중점을 두고있음;\",text3180:\"소화기관 암, 마이코 박테리아 그리고 클로스트리듐 디피실리균 감염을 포함한 질병에서 숙주-미생물 역학에 대한 전문 지식을 갖춘 임상 과학자;\",text3181:\"New England의 의학 저널 및 Nature Genetics를 포함한 상위 저널에 50개 이상의 논문 게재;\",text3182:\"다기관 유행병학 연구, 2/3 약물 시험의 연구원.\",text3183:\"DR ALBERT LEUNG\",text3184:\"고문\",text3185:\"홍콩에 본사를 둔 Beauchamp International Development 유한 회사의 재무 및 사업 개발 컨설턴트;\",text3186:\"홍콩의 Citicorp International에서 전임 차관 부사장으로서 주요 IPO 기업 재무 관련 업무 수행;\",text3187:\"1977년부터 1987년까지 영국의 회계 법인에서 10년 동안의 회계 및 감사 경력;\",text3188:\"현재 홍콩 증권 거래소에서 상장된 다양한 공개 회사의 비상임 이사;\",text3189:\"홍콩 신장 재단 이사;\",text3190:\"상해 금융 & 경제 대학교 박사 (경제);\",text3191:\"Brunel University (영국)의 Henley Business School에서 MBA;\",text3192:\"홍콩 공인 회계사 협회 회원\",text3193:\"DR KWOK KA WAI\",text3194:\"고문\",text3195:\"홍콩 대학교 기계학과 조교수;\",text3196:\"이미지-유도 로봇 수술과 관련된 마스터-슬레이브 컨트롤 인터페이스에 중점을 두고 연구함;\",text3197:\"Imperial College London에서 컴퓨터 학과 박사학위 취득;\",text3198:\"홍콩 중문 대학교에서 자동화 및 컴퓨터 지원 공학 분야에서 BEng 그리고 MPhil 학위 취득;\",text3199:\"현재 Georgia와 Brigham 대학교와 하버드 의과대학의 여성 병원에서 공동으로 주최한 박사학위 취득 후의 연구를 지원하고 있는 Croucher Foundation Fellowship의 수취인\",text3200:\"JOE HUI\",text3201:\"고문\",text3202:\"투자 책임자, 양적 전략, Eagle Eye 그룹;\",text3203:\"HKU 항공 중국 비즈니스 연구소 초빙 강사;\",text3204:\"중국 인민 대학교 HanQing Advanced Institute of Economics and Finance 초빙 강사;\",text3205:\"JLPAY 중국의 전임 수석 투자 고문;\",text3206:\"홍콩 및 중국 자금에 대한 전임 양적 투자 컨설턴트;\",text3207:\"홍콩 대학교 공과 대학 공학부 수석 선임 연구원, 양적 금융, 블록 체인 기술 그리고 인공 지능 연구에 관심 있음;\",text3208:\"Tsinghua University (베이징)에서 금융학 석사.\",text3209:\"DR OWEN KO\",text3210:\"고문\",text3211:\"홍콩 중문 대학교 (“CUHK”) 의대와 치료학과의 임상 강사;\",text3212:\"Nature지에 논문 1권과 Nature Neuroscience에 논문 2권을 발표함;\",text3213:\"2005년 CUHK에서 의학 학사 그리고 외과 프로그램 학사, 생명의학 학교의 Wing-ho Yung 교수의 멘토링 아래에 의과 과학 학사 (BMedSci) 획득;\",text3214:\"Thomas Mrsic-Flogel 지도교수의 지도 아래 University College London (UCL) 의 신경 과학과에서 박삭학위 취득. 그의 획기적인 연구로 홍콩 최초로 신경 생물학 분야에 Eppendorf & Science 상을 수상함.\",text3215:\"SHELL CHUNG\",text3216:\"고문\",text3217:\"Alpacian 유한 회사의 보안 컨설턴트, 홍콩 기반 엔터프라이즈 I.T. 보안 회사;\",text3218:\"정보 보안 및 컴퓨터 법의학 전문가;\",text3219:\"웹 및 모바일 어플리케이션 보안 평가 전문가;\",text3220:\"정보 보안 및 기술 문제에 상장된 회사 또는 기업에 전문적인 자문 제공;\",text3221:\"정보 보안 위험 관리 체제, 사고 대응 & 컴퓨터 법의학 조사에 익숙.\",text3222:\"DR KEVIN CHAN\",text3223:\"고문\",text3224:\"금융 및 자산 관리 분야에서 20년 이상의 경력;\",text3225:\"현재 투자자에게 독점적인 헤지 펀드, 사모 펀드 및 직접 투자 기회를 제공하는Cachet Asset Management의 전무 이사;\",text3226:\"이전에는 Cornucopia Capital Partners의 관리 파트너 였음;\",text3227:\"뉴욕시의 Goldman Sachs Asset Management 그리고 도쿄의 Sparx Asset Management에서 연구와 계량 분석가로 근무함;\",text3228:\"펜실베니아 대학교에서 관리 및 기술 분야에서 복수 학위를 취득함;\",text3229:\"Massachusetts Institute of Technology에서 재무 경제학 박사학위를 취득함.\",text3236:\"VIRGINIA LAM\",text3237:\"마케팅 고문\",text3238:\"블록체인 혁신에 열정을 가지고 있는 스타트업-상장회사에서 15년 이상의 경험을 가지고 있음;\",text3239:\"COINS Marketing의 공동 설립자, 핀테크와 블록체인 프로젝트의 파트너;\",text3240:\"호주 시드니에 본사를 둔 블록체인 기술 회사인 X Blockchain Pty Ltd가 소유한 글로벌 암호화 환전소인 Xbrick의 마케팅 책임자;\",text3241:\"The Abyss의 마케팅 담당자, 게이머 및 개발자를 위한 암호화 보상 에코시스템;\",text3242:\"디지털 마케팅 대행사인 V Partnership의 공동 설립자;\",text3243:\"아시아 전역의 전자 상거래 회사인 Ensogo Limited (ASX: E88)의 전임 마케팅 이사;\",text3244:\"BA – University of Sydney, 영어와 심리학 전공.\",text3245:\"DOUGLAS CHING\",text3246:\"마케팅 고문\",text3247:\"전자 상거래 및 소비자 전자 제품 사업 전반에 걸친 디지털 마케팅 및 소셜 미디어 마케팅을 포함한 20년 이상의 마케팅 경험;\",text3248:\"OOKEA 그룹의 두개의 마케팅 회사의 공동 창업자: 코인 마케팅 (토큰 판매 컨설턴트 기관) 그리고 V 파트너십 (디지털 마케팅 대행사);\",text3249:\"중국 본사에 설립된 Ensogo Limited (ASX:E88)의 전임 본부장;\",text3250:\"공인받은 구글 개인 분석가; Cisco CCNA; 마이크로소프트 MCSE + MCDBA;\",text3251:\"영국의 Middlesex University에서 전자 상거래 석사 학위 취득;\",text3252:\"BA – 캐나다 University of Toronto에서 경재학 학사.\"}}},function(t,e,n){\"use strict\";var i=n(0).getTranslatedText,a=n(0).strReplace,o=n(2).teamMemberData,s=n(2).advisorsData,r=n(7),x=n(6),l=n(5),c=n(4),d=n(1).getPdfDoc,u=n(3);function g(){var t=location.href.match(/lang=([a-z A-Z -]+)/g);return console.log(t),\"en\"}function m(){$(\".overlay\").hide(),$(\"#mobile-menu\").animate({right:-200},200,function(){$(\"#mobile-menu\").hide()})}function h(){return window.innerWidth<=860?4:window.innerWidth<=1060?5:6}var p={numTeamMemberShown:h(),numAdvisorShown:h(),numVideoShown:4,language:g(),isLanguageSubMenuOpen:!1,init:function(){var t=this;$(\"a[href*=\\\\#]:not([href=\\\\#])\").click(function(){if(location.pathname.replace(/^\\//,\"\")==this.pathname.replace(/^\\//,\"\")&&location.hostname==this.hostname){var t=$(this.hash);if(t.hasClass(\"faq-area\"))return $(\".section-cat-one\").hide(),$(\".section-cat-two\").show(),$(\"html,body\").animate({scrollTop:t.offset().top-100},700),!1;if((t=t.length?t:$(\"[name=\"+this.hash.slice(1)+\"]\")).length)return $(\".section-cat-one\").show(),$(\".section-cat-two\").hide(),$(window).width()<991&&($(\".menu-trigger\").removeClass(\"active\"),$(\".header-area .nav\").slideUp(200)),$(\"html,body\").animate({scrollTop:t.offset().top-100},700),!1}}),$(window).scroll(function(t){var e=$(this).scrollTop();e>80?$(\".header\").css(\"background-color\",\"rgba(0,0,0,1)\"):$(\".header\").css(\"background-color\",\"rgba(0,0,0,\"+e/80+\")\")}),window.onresize=function(e){t.numTeamMemberShown=Math.max(t.numTeamMemberShown,h()),t.numAdvisorShown=Math.max(t.numAdvisorShown,h()),t.updateTeamMemberList(),t.updateAdvisorList()},$(\".adv\").html(this.getPromotionPopup()),this.showPromotionPopup(),this.getSlider(),this.updateVideos(),this.updateMediaAndPartners(),this.updateTeamMemberList(),this.updateAdvisorList(),this.addButtonListener(),this.startCounter(),this.updateCounterText(),this.updateTitle(),c.render(),c.updateTable(this.language)},addButtonListener:function(){var t=this;$(\"#btn-more-videos\").click(function(){$(\"#video-list .item:hidden\").slideDown(),$(\"#btn-more-videos\").hide(),t.numVideoShown=l.length}),$(\"#btn-team-more\").click(function(){$(\"#team-member-list .team-round:hidden\").slideDown(),$(\"#btn-team-more\").hide(),t.numTeamMemberShown=o.length}),$(\"#btn-advisors-more\").click(function(){$(\"#advisor-list .team-round:hidden\").slideDown(),$(\"#btn-advisors-more\").hide(),t.numAdvisorShown=s.length}),$(\"#mobile-menu-btn\").on(\"click\",function(){$(\".overlay\").show(),$(\"#mobile-menu\").show(),$(\"#mobile-menu\").animate({right:0},200)}),$(\".mobile-menu\").on(\"click\",function(){m()}),$(\".menu-area\").on(\"click\",function(){m()}),$(\".menu-area .list-group .close-when-click\").on(\"click\",function(){m()}),$(\".language-selector-container\").mouseover(function(){$(\".language-selector-container\").addClass(\"expanded\"),$(\".language-selector\").show()}),$(\".language-selector-container\").mouseout(function(){$(\".language-selector-container\").removeClass(\"expanded\"),$(\".language-selector\").hide()}),$(\".btn-contributors\").click(function(){t.initModal(i(t.language,\"text0005\"),u.getContributionSection(t.language))}),$(\".btn-learn\").click(function(){t.initModal(i(t.language,\"text2001\"),u.getLearnMoreContent(t.language))}),$(\".btn-language\").click(function(){event.stopPropagation(),t.isLanguageSubMenuOpen?($(\".sub-menu\").animate({right:0}),t.isLanguageSubMenuOpen=!1):($(\".sub-menu\").animate({right:200}),t.isLanguageSubMenuOpen=!0)}),$(\".btn-lang-item\").click(function(){$(\".sub-menu\").animate({right:0}),t.isLanguageSubMenuOpen=!1}),$(\".btn-show-promotion\").mouseover(function(){t.hoverPromotionPopup()}),$(\".btn-show-promotion\").mouseout(function(){t.hidePromotionPopup()})},getPDFDom:function(){return'<div class=\"pdf-frame\"><div id=\"pdfContainer\"></div></div>'},getBreakPointsScale:function(){var t=1;return window.innerWidth/window.innerHeight>=1400/1012?t=Math.abs(window.innerWidth/1400):window.innerWidth/window.innerHeight>=1e3/1012?t=Math.abs(window.innerWidth/1e3):window.innerWidth/window.innerHeight>=800/1012?t=Math.abs(window.innerWidth/1e3):window.innerWidth/window.innerHeight>=600/1012&&(t=Math.abs(window.innerWidth/1e3)),t},getSlider:function(){var t=this.getBreakPointsScale();$(\".regular\").slick({dots:!1,infinite:!0,slidesToShow:5,slidesToScroll:1,variableWidth:!0,centerMode:!0,autoplay:!0,responsive:[{breakpoint:1400*t,settings:{slidesToShow:4,slidesToScroll:1,infinite:!0,dots:!1}},{breakpoint:1e3*t,settings:{slidesToShow:3,slidesToScroll:1,infinite:!0,dots:!1}},{breakpoint:800*t,settings:{slidesToShow:2,slidesToScroll:1,infinite:!0,dots:!1}},{breakpoint:600*t,settings:{slidesToShow:1,slidesToScroll:1,infinite:!0,dots:!1}}]})},getVideos:function(){for(var t=\"\",e=this.language,n=0;n<l.length;n++){var a=l[n].path,o=i(e,l[n].label),s=l[n].id,r=n<this.numVideoShown?\"block\":\"none\";t+='<div class=\"item\" style=\"display:'.concat(r,'\"> \\n                        <a href=\"#\" onclick=\"window.openVideo(').concat(s,')\" data-toggle=\"modal\" data-target=\"#modal-container\">\\n                            <img src=\"').concat(a,'\" />\\n                            <h3 class=\"subtitle\">').concat(o,\"</h3>\\n                        </a>\\n                    </div>\")}return t},getVideoContent:function(t){return'<div class=\"popup-video-container\"><div class=\"video-frame\"><iframe class=\"embed-responsive-item\" src=\"'.concat(t,'\" allowfullscreen=\"\"></iframe></div></div>')},getMediaOrPartners:function(t){for(var e=\"\",n=0;n<t.length;n++){var i=t[n],a=i.url,o=void 0===a?\"\":a,s=i.image,r=void 0===s?\"\":s;e+=\"\"===o?'<li><img src=\"'.concat(r,'\" /></li>'):'<li><a target=\"_blank\" href=\"'.concat(o,'\"><img src=\"').concat(r,'\" /></a></li>')}return e},getTeamMemberDom:function(t,e,n,i,a,o,s){var r=s?\"list-item\":\"none\";return'<div class=\"team-round\" style=\"display: '.concat(o?\"block\":\"none\",';\">\\n                    <div class=\"profile\">\\n                        <div class=\"img\">\\n                            <img src=\"').concat(e,'\" alt=\"').concat(t,'\" width=\"120\" height=\"120\">\\n                        </div>\\n                        <div class=\"name\"><span class=\"f4\">').concat(t,'</span></div>\\n                        <div class=\"title\"><h6>').concat(n,'</h6></div>\\n                        <div class=\"link\">\\n                            <ul class=\"social\">\\n                                <li style=\"display: ').concat(r,';\"><a class=\"btn-info\" onclick=\"window.showDetailInfo(').concat(a,');\" href=\"#\" data-toggle=\"modal\" data-target=\"#modal-container\"><div class=\"icon icon-profile\"></div></a></li>\\n                                <li><a target=\"_blank\" href=\"').concat(i,'\"><div class=\"icon icon-linkedin\"></div></a></li>\\n                                <div class=\"clear\"></div>\\n                            </ul>\\n                        </div>\\n                    </div>\\n                </div>')},getTeamMemberList:function(){for(var t=\"\",e=this.language,n=0;n<o.length;n++){var a=i(e,o[n].name),s=i(e,o[n].title),r=o[n].image,x=o[n].linkedin,l=o[n].id,c=n<this.numTeamMemberShown;t+=this.getTeamMemberDom(a,r,s,x,l,c,!1)}return t},getAdvisorList:function(){for(var t=\"\",e=this.language,n=0;n<s.length;n++){var a=i(e,s[n].name),o=i(e,s[n].title),r=s[n].image,x=s[n].linkedin,l=s[n].id,c=n<this.numAdvisorShown;t+=this.getTeamMemberDom(a,r,o,x,l,c,!0)}return t},showDetailInfo:function(t){for(var e,n=0;n<s.length;n++)if(s[n].id===t){e=s[n];break}this.initModal(\"\",this.getMemberDetailedInfo(e.image,e.name,e.title,e.desc),\"team-member-popup\")},getMemberDetailedInfo:function(){for(var t=arguments.length>0&&void 0!==arguments[0]?arguments[0]:\"\",e=arguments.length>1&&void 0!==arguments[1]?arguments[1]:\"\",n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:\"\",a=arguments.length>3&&void 0!==arguments[3]?arguments[3]:[],o=\"<ul>\",s=0;s<a.length;s++){var r=i(this.language,a[s]);o+=\"<li>\".concat(r,\"</li>\")}o+=\"</ul>\";var x=i(this.language,e),l=i(this.language,n);return'<div class=\"member-info-container\">\\n            <div class=\"member-image\">\\n                <img src=\"'.concat(t,'\" />\\n            </div>\\n            <div class=\"info\">\\n                <ul>\\n                    <li class=\"name popup-name f4\">').concat(x,'</li>\\n                    <li class=\"title popup-title\"><h6>').concat(l,'</h6></li>\\n                    <li class=\"desc\"><h5>\\n                        ').concat(o,\"\\n                    </h5></li>\\n                </ul>\\n            </div>\\n        </div>\")},hoverPromotionPopup:function(){$(\".adv\").show()},showPromotionPopup:function(){this.initModal(\"\",this.getPromotionPopup(),\"promotion-popup\"),$(\"#modal-container\").modal(\"show\")},hidePromotionPopup:function(){$(\".adv\").hide()},getPromotionPopup:function(){for(var t=[{image:{en:\"./assets/img/promotion/50free.png\",zhcn:\"./assets/img/promotion/50free-cn.png\",kr:\"./assets/img/promotion/50free-kr.png\"},msg:i(this.language,\"text0229\"),class:\"blue\"},{image:{en:\"./assets/img/promotion/5bonus.png\",zhcn:\"./assets/img/promotion/5bonus-cn.png\",kr:\"./assets/img/promotion/5bonus-kr.png\"},msg:i(this.language,\"text0230\")+'<br><span class=\"f6 f50\">'+i(this.language,\"text0231\")+\"</span>\",class:\"green\"}],e=\"\",n=0;n<t.length;n++){var a=t[n].image[this.language],o=t[n].msg,s=t[n].class;e+='<div class=\"tb-block '.concat(s,'\">\\n                            <div class=\"img-container\"><img src=\"').concat(a,'\" /></div>\\n                            <div class=\"msg-container\">\\n                                <span class=\"f7 f100\">').concat(o,\"</span>\\n                            </div>\\n                        </div>\")}return'<div class=\"promotion-area\">\\n                    '.concat(e,\"\\n                </div>\")},openVideo:function(t){for(var e,n=0;n<l.length;n++)l[n].id===t&&(e=l[n]);var a=i(this.language,e.label),o=e.url,s=o[this.language]?o[this.language]:o.en;this.initModal(a,this.getVideoContent(s),\"video-popup\")},updateTeamMemberList:function(){$(\"#team-member-list\").html(this.getTeamMemberList())},updateAdvisorList:function(){$(\"#advisor-list\").html(this.getAdvisorList())},updateMediaAndPartners:function(){$(\"#media-list\").html(this.getMediaOrPartners(r)),$(\"#partner-list\").html(this.getMediaOrPartners(x))},updateVideos:function(){$(\"#video-list\").html(this.getVideos())},updateCounterText:function(){$(\".flip-clock-divider.days span.flip-clock-label\").html(i(this.language,\"text0199\")),$(\".flip-clock-divider.hours span.flip-clock-label\").html(i(this.language,\"text0200\")),$(\".flip-clock-divider.minutes span.flip-clock-label\").html(i(this.language,\"text0201\")),$(\".flip-clock-divider.seconds span.flip-clock-label\").html(i(this.language,\"text0202\"))},updateTitle:function(){window.document.title=i(this.language,\"text0228\")},changeLang:function(t){this.language=t,window.localStorage.setItem(\"aenco-lang\",t),this.showPromotionPopup(),this.updateTeamMemberList(),this.updateAdvisorList(),this.updateVideos(),this.updateCounterText(),this.updateTitle(),c.updateTable(this.language)},startCounter:function(){var t=Date.now(),e=(Date.parse(\"July 27, 2018 00:00:00\")-t)/1e3;$(\".clock\").FlipClock(e,{clockFace:\"DailyCounter\",countdown:!0})},initModal:function(){var t=arguments.length>0&&void 0!==arguments[0]?arguments[0]:\"\",e=arguments.length>1&&void 0!==arguments[1]?arguments[1]:\"\",n=\"modal-dialog \"+(arguments.length>2&&void 0!==arguments[2]?arguments[2]:\"\");$(\"#modal-container .modal-title\").html(t),$(\"#modal-container .modal-dialog\").attr(\"class\",n),$(\"#modal-container #modal-body-content\").html(e)}};p.init(),angular.module(\"todoApp\",[]).controller(\"AppController\",[\"$scope\",\"$http\",\"$sce\",function(t,e,n){var o=this;o.done=1,o.lang=g(),o.getTranslatedText=function(t){var e=i(o.lang,t);return n.trustAsHtml(e)},o.getTranslatedTextWithPlaceholder=function(t,e,s){var r=i(o.lang,t);return r=a(r,e,s),n.trustAsHtml(r)},o.getTranslatedTextWithUrl=function(t,e){var s=i(o.lang,t);return s=a(s,\"<a>\",'<a target=\"_blank\" href=\"'+e+'\">'),n.trustAsHtml(s)},o.getTranslatedTextWithPdf=function(t,e){var s=d(e,o.lang).path,r=i(o.lang,t);return r=a(r,\"<a>\",'<a target=\"_blank\" href=\"'+s+'\">'),n.trustAsHtml(r)},o.changeLang=function(t){o.lang=t,p.changeLang(t)},o.getPDFPath=function(t){return d(t,o.lang).path},o.getCoreVideoUrl=function(){var t=\"https://www.youtube.com/embed/kfWu3fKLe2I?rel=0\";switch(o.lang){case\"zhcn\":t=\"https://www.youtube.com/embed/U5A5d22b17E\"}var e='<iframe class=\"embed-responsive-item\" src=\"'+t+'\" allowfullscreen=\"\"></iframe>';return n.trustAsHtml(e)}}]),window.showDetailInfo=p.showDetailInfo.bind(p),window.openVideo=p.openVideo.bind(p)}]);","extractedComments":[]}